# EDGAR Filing Document

**Accession Number:** 0001843586
**File Stem:** 0000950170-25-097884
**Filing Date:** 2025-7
**Character Count:** 162329
**Document Hash:** bbcda8e0f2585f3bb0d06ba6ed7e4da1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-097884.hdr.sgml**: 20250723

**ACCESSION NUMBER**: 0000950170-25-097884

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250723

**DATE AS OF CHANGE**: 20250723

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Oatly Group AB
- **CENTRAL INDEX KEY:** 0001843586
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40401
- **FILM NUMBER:** 251143098

**BUSINESS ADDRESS:**
- **STREET 1:** C/O OATLY GROUP
- **STREET 2:** ANGFARJEKAJEN 8
- **CITY:** MALMO
- **STATE:** V7
- **ZIP:** 211 19
- **BUSINESS PHONE:** 46 418 47 5500

**MAIL ADDRESS:**
- **STREET 1:** C/O OATLY GROUP
- **STREET 2:** ANGFARJEKAJEN 8
- **CITY:** MALMO
- **STATE:** V7
- **ZIP:** 211 19

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Havre Global AB
- **DATE OF NAME CHANGE:** 20210201

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

------

**REPORT OF FOREIGN PRIVATE ISSUER<br>PURSUANT TO RULE 13a-16 OR 15d-16<br>OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of July 2025**

**Commission File Number: 001-40401**

**Oatly Group AB**

(Translation of registrant's name into English)

------

**Ångfärjekajen 8**

**211 19 Malmö**

**Sweden**

(Address of principal executive office)

------

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

------

The information included in this Report of Foreign Private Issuer on Form 6-K is hereby incorporated by reference into the registration statements on Form S-8, as amended (File Number 333-256316) and Form F-3, as amended (File Number 333-286101) of the Company (including any prospectuses forming a part of such registration statements), hereby amending them, and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

------

![img33928959_0.jpg](img33928959_0.jpg)

**Oatly Group AB**

**Interim condensed consolidated financial statements**

**For the three and six months ended June 30, 2025**

------

**Table of contents**

---

| | |
|:---|:---|
| **PART I – FINANCIAL INFORMATION** |  |
| [<u>Item 1. Financial Statements</u>](#item_1_financial_statements) |  |
| [<u>Interim condensed consolidated statement of operations</u>](#statement_of_operations) | 1 |
| [<u>Interim condensed consolidated statement of comprehensive loss</u>](#statement_of_comprehensive_loss) | 2 |
| [<u>Interim condensed consolidated statement of financial position</u>](#statement_of_financial_position) | 3 |
| [<u>Interim condensed consolidated statement of changes in equity</u>](#statement_of_changes_in_equity) | 4 |
| [<u>Interim condensed consolidated statement of cash flows</u>](#statement_of_cash_flows) | 5 |
| [<u>Notes to the interim condensed consolidated financial statements</u>](#notes_to_interim_condensed_consolidated_) | 6 |
| [<u>Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item_2_managements_discussion_analysis_f) | 24 |
| [<u>Item 3. Quantitative and Qualitative Disclosures About Market Risk</u>](#item_3_qualitative_quantitative_disclosu) | 40 |
| **PART II – OTHER INFORMATION** |  |
| [<u>Item 1. Legal Proceedings</u>](#item_1_legal_proceedings) | 40 |
| [<u>Item 1A. Risk Factors</u>](#item_1a_risk_factors) | 40 |
| [<u>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</u>](#item_2_unregistered_sales_equity_securit) | 40 |
| [<u>Item 3. Defaults Upon Senior Securities</u>](#item_3_defaults_upon_senior_securities) | 40 |
| [<u>Signatures</u>](#signatures) | 41 |

---

------

**Part I – FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**Interim condensed consolidated statement of operations**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(Unaudited)** |  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| **<br>(in thousands of U.S. dollars, except share and per share and ADS data)** | **Note** | **2025** | **2024** | **2025** | **2024** |
| Revenue | 5 | 208354 | 202195 | 405884 | 401350 |
| Cost of goods sold |  | (140729) | (143239) | (275929) | (288496) |
| **Gross profit** |  | **67625** | **58956** | **129955** | **112854** |
| Research and development expenses |  | (4605) | (10898) | (8996) | (15540) |
| Selling, general and administrative expenses |  | (84111) | (84261) | (161609) | (163003) |
| Other operating income and (expenses), net |  | (1025) | (2876) | (57) | (1803) |
| **Operating loss** |  | **(22116)** | **(39079)** | **(40707)** | **(67492)** |
| Finance income and (expenses), net | 7 | (31916) | 10389 | (22505) | (6988) |
| **Loss before tax** |  | **(54032)** | **(28690)** | **(63212)** | **(74480)** |
| Income tax expense | 8 | (1914) | (1751) | (5265) | (1805) |
| **Loss for the period** |  | **(55946)** | **(30441)** | **(68477)** | **(76285)** |
| Attributable to: |  |  |  |  |  |
| Shareholders of the parent |  | (55911) | (30384) | (68341) | (76183) |
| Non-controlling interests |  | (35) | (57) | (136) | (102) |
| **Loss per share, attributable to shareholders of the parent:** |  |  |  |  |  |
| Basic and diluted | 24 | (0.09) | (0.05) | (0.11) | (0.13) |
| **Loss per ADS, attributable to shareholder of the parent <br>(1 ADS representing 20 ordinary shares):** |  |  |  |  |  |
| Basic and diluted | 24 | (1.86) | (1.02) | (2.28) | (2.56) |
| **Weighted average common shares outstanding:** |  |  |  |  |  |
| Basic and diluted | 24 | 601195247 | 596242505 | 599884824 | 595654647 |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

**Interim condensed consolidated statement of comprehensive loss**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| **(in thousands of U.S. dollars)** | **2025** | **2024** | **2025** | **2024** |
| **Loss for the period** | **(55946)** | **(30441)** | **(68477)** | **(76285)** |
| **Other comprehensive income/(loss):** |  |  |  |  |
| Items that may be subsequently reclassified to the consolidated statement of operations (net of tax): |  |  |  |  |
| Exchange differences from translation of foreign operations | 27330 | (1228) | 52027 | (20460) |
| **Total other comprehensive income/(loss) for the period** | **27330** | **(1228)** | **52027** | **(20460)** |
| **Total comprehensive loss for the period** | **(28616)** | **(31669)** | **(16450)** | **(96745)** |
| Attributable to: |  |  |  |  |
| Shareholders of the parent | (28583) | (31605) | (16318) | (96627) |
| Non-controlling interests | (33) | (64) | (132) | (118) |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

**Interim condensed consolidated statement of financial position**

---

| | | | |
|:---|:---|:---|:---|
| **(Unaudited)** | **Note** | **June 30, 2025** | **December 31, 2024** |
| **(in thousands of U.S. dollars)** |  |  |  |
| **ASSETS** |  |  |  |
| **Non-current assets** |  |  |  |
| Intangible assets | 9 | 133628 | 116208 |
| Property, plant and equipment | 10 | 304565 | 294199 |
| Right-of-use assets | 11 | 43541 | 45555 |
| Other non-current receivables | 1213 | 45140 | 44331 |
| Deferred tax assets | 8 | 4698 | 4561 |
| **Total non-current assets** |  | **531572** | **504854** |
| **Current assets** |  |  |  |
| Inventories | 14 | 65851 | 65602 |
| Trade receivables | 15 | 102597 | 103366 |
| Current tax assets |  | 5933 | 6095 |
| Other current receivables | 16 | 17968 | 15738 |
| Prepaid expenses |  | 11203 | 9402 |
| Cash and cash equivalents | 17 | 67931 | 98923 |
| **Total current assets** |  | **271483** | **299126** |
| **TOTAL ASSETS** |  | **803055** | **803980** |
| **EQUITY AND LIABILITIES** |  |  |  |
| **Equity** | 18 |  |  |
| Share capital |  | 107 | 106 |
| Treasury shares |  | (0) | (0) |
| Other contributed capital |  | 1628045 | 1628045 |
| Other reserves |  | (222137) | (274160) |
| Accumulated deficit |  | (1310599) | (1249303) |
| **Equity attributable to shareholders of the parent** |  | **95416** | **104688** |
| Non-controlling interests |  | 1303 | 1435 |
| **Total equity** |  | **96719** | **106123** |
| **Liabilities** |  |  |  |
| **Non-current liabilities** |  |  |  |
| Lease liabilities | 11 | 29508 | 31724 |
| Liabilities to credit institutions | 19 | 115746 | 116216 |
| Provisions | 20 | 9317 | 14857 |
| **Total non-current liabilities** |  | **154571** | **162797** |
| **Current liabilities** |  |  |  |
| Lease liabilities | 11 | 13473 | 13359 |
| Convertible Notes | 1321 | 328981 | 324395 |
| Liabilities to credit institutions | 19 | 4899 | 5757 |
| Trade payables |  | 64688 | 60152 |
| Current tax liabilities |  | 1349 | 1476 |
| Other current liabilities |  | 7568 | 7998 |
| Accrued expenses | 22 | 112675 | 103719 |
| Provisions | 20 | 18132 | 18204 |
| **Total current liabilities** |  | **551765** | **535060** |
| **Total liabilities** |  | **706336** | **697857** |
| **TOTAL EQUITY AND LIABILITIES** |  | **803055** | **803980** |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

**Interim condensed consolidated statement of changes in equity**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **(Unaudited)<br>(in thousands of U.S. dollars)** | **Note** | **Share capital** | **Treasury shares** | **Other contributed capital** | **Other reserves** | **Accumulated deficit** | **Equity attributable to shareholders of the parent** | **Non-controlling interests** | **Total equity** |
| **Balance at December 31, 2024** | 18 | **106** | **(0)** | **1628045** | **(274160)** | **(1249303)** | **104688** | **1435** | **106123** |
| Loss for the period |  |  |  |  |  | (12430) | (12430) | (101) | (12531) |
| Other comprehensive income |  |  |  |  | 24695 |  | 24695 | 2 | 24697 |
| **Total comprehensive income for the period** |  | **—** | **—** | **—** | **24695** | **(12430)** | **12265** | **(99)** | **12166** |
| Share-based compensation | 6 |  |  |  |  | 3592 | 3592 |  | 3592 |
| **Balance at March 31, 2025** |  | **106** | **(0)** | **1628045** | **(249465)** | **(1258141)** | **120545** | **1336** | **121881** |
| Loss for the period |  |  |  |  |  | (55911) | (55911) | (35) | (55946) |
| Other comprehensive income |  |  |  |  | 27328 |  | 27328 | 2 | 27330 |
| **Total comprehensive loss for the period** |  | **—** | **—** | **—** | **27328** | **(55911)** | **(28583)** | **(33)** | **(28616)** |
| Issue of shares |  | 1 | (0) |  |  |  | 1 |  | 1 |
| Share-based compensation | 6 |  |  |  |  | 3453 | 3453 |  | 3453 |
| **Balance at June 30, 2025** |  | **107** | **(0)** | **1628045** | **(222137)** | **(1310599)** | **95416** | **1303** | **96719** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **(Unaudited)<br>(in thousands of U.S. dollars)** | **Note** | **Share capital** | **Treasury shares** | **Other contributed capital** | **Other reserves** | **Accumulated deficit** | **Equity attributable to shareholders of the parent** | **Non-controlling interests** | **Total equity** |
| **Balance at December 31, 2023** | 18 | **105** | **(0)** | **1628045** | **(233204)** | **(1060952)** | **333994** | **1787** | **335781** |
| Loss for the period |  |  |  |  |  | (45799) | (45799) | (45) | (45844) |
| Other comprehensive loss |  |  |  |  | (19223) |  | (19223) | (9) | (19232) |
| **Total comprehensive loss for the period** |  | **—** | **—** | **—** | **(19223)** | **(45799)** | **(65022)** | **(54)** | **(65076)** |
| Share-based compensation | 6 |  |  |  |  | 2615 | 2615 |  | 2615 |
| **Balance at March 31, 2024** |  | **105** | **(0)** | **1628045** | **(252427)** | **(1104136)** | **271587** | **1733** | **273320** |
| Loss for the period |  |  |  |  |  | (30384) | (30384) | (57) | (30441) |
| Other comprehensive loss |  |  |  |  | (1221) |  | (1221) | (7) | (1228) |
| **Total comprehensive loss for the period** |  | **—** | **—** | **—** | **(1221)** | **(30384)** | **(31605)** | **(64)** | **(31669)** |
| Issue of shares |  | 1 | (0) |  |  |  | 0 |  | 0 |
| Share-based compensation | 6 |  |  |  |  | 4179 | 4179 |  | 4179 |
| **Balance at June 30, 2024** |  | **106** | **(0)** | **1628045** | **(253648)** | **(1130341)** | **244162** | **1669** | **245831** |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

**Interim condensed consolidated statement of cash flows**

---

| | | | |
|:---|:---|:---|:---|
| **(Unaudited)** |  | **Six months ended June 30,** | **Six months ended June 30,** |
| **(in thousands of U.S. dollars)** | **Note** | **2025** | **2024** |
| **Operating activities** |  |  |  |
| Net loss |  | (68477) | (76285) |
| Adjustments to reconcile net loss to net cash flows |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;—Depreciation of property, plant and equipment and right-of-use assets and amortization of intangible assets | 91011 | 23475 | 25321 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Write-downs of inventories | 14 | 4360 | 517 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Impairment (gain)/loss on trade receivables | 15 | (16) | 176 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Share-based compensation | 6 | 7045 | 6794 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Movements in provisions | 20 | (7670) | (35507) |
| &nbsp;&nbsp;&nbsp;&nbsp;—Finance (income) and expenses, net | 7 | 22505 | 6988 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Income tax expense | 8 | 5265 | 1805 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Impairment reversal related to discontinued construction of production facilities |  |  | 1747 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Other |  | (86) | 1317 |
| Interest received |  | 1035 | 5897 |
| Interest paid |  | (11829) | (13002) |
| Income tax paid |  | (1674) | (3767) |
| Changes in working capital: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;—Increase in inventories | 14 | (959) | (14151) |
| &nbsp;&nbsp;&nbsp;&nbsp;—Decrease in trade receivables, other current receivables, prepaid expenses | 1516 | 6382 | 15923 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Increase/(decrease) in trade payables, other current liabilities, accrued expenses | 22 | 5639 | (9786) |
| **Net cash flows used in operating activities** |  | **(15005)** | **(86013)** |
| **Investing activities** |  |  |  |
| Purchase of intangible assets | 9 | (921) | (773) |
| Purchase of property, plant and equipment | 10 | (9778) | (19647) |
| Proceeds from sale of property, plant and equipment |  | 70 | 20392 |
| Other |  | 409 | 886 |
| **Net cash flows (used in)/from investing activities** |  | **(10220)** | **858** |
| **Financing activities** |  |  |  |
| Repayment of liabilities to credit institutions | 19 | (1320) | (1360) |
| Payment of loan transaction costs | 7 | (1020) | (4965) |
| Repayment of lease liabilities | 11 | (5811) | (13888) |
| **Cash flows used in financing activities** |  | **(8151)** | **(20213)** |
| **Net decrease in cash and cash equivalents** |  | **(33376)** | **(105368)** |
| Cash and cash equivalents at the beginning of the period |  | 98923 | 249299 |
| Exchange rate differences in cash and cash equivalents |  | 2384 | (1203) |
| **Cash and cash equivalents at the end of the period** | 17 | **67931** | **142728** |

---

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

------

**Notes to the interim condensed consolidated financial statements**

*(unaudited)*

*(in thousands of U.S. dollars unless otherwise stated)*

# **Note 1. Corporate information** 
Oatly Group AB (the "Company" or the "parent") is a public limited company incorporated and domiciled in Sweden. The Company's registered office is located at Ångfärjekajen 8, Malmö, Sweden.

Oatly Group AB and its subsidiaries (together, the "Group") manufacture, distribute and sell oat-based products.

# **Note 2. Summary of accounting policies** 
The interim condensed consolidated financial statements of Oatly Group AB for the three and six months ended June 30, 2025 and 2024 have been prepared in accordance with IAS 34 *Interim Financial Reporting*. The Group has prepared the financial statements on the basis that it will continue to operate as a going concern, and there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future, and not less than 12 months from the end of the reporting period. In forming this judgment the Group has taken into consideration principal conditions, events and assumptions in relation to the Group's ability to meet its financial covenants and other obligations. The accounting policies adopted are consistent with those of the previous financial year and corresponding interim reporting period.

The interim financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary to fairly present the information set forth herein. The interim condensed consolidated financial statements should be read in conjunction with the Group's consolidated financial statements for the year ended December 31, 2024, as they do not include all the information and disclosures required in the annual consolidated financial statements. Interim results are not necessarily indicative of the results for a full year. The interim condensed consolidated financial statements are presented in thousands of U.S. dollars, unless otherwise stated.

On February 18, 2025, the Company completed a ratio change whereby the ratio of the Company's American Depositary Shares ("ADSs") to ordinary shares was changed from one ADS representing one ordinary share to one ADS representing twenty ordinary shares (the "ADS Ratio Change"). All numbers in these interim condensed consolidated financial statements, including references to price per ADS and a specific number of ADSs, restricted stock units ("RSUs") or stock options, reflect an ADS to ordinary share ratio of 1:20 (unless the context clearly indicates otherwise).

***New and amended standards and interpretations issued but not yet adopted***

There are no IFRS® Accounting Standards as issued by the International Accounting Standards Board ("IFRS Accounting standards") that are expected to have a material impact on the Group in the current or future reporting periods or on foreseeable future transactions, other than those included in the 2024 Annual Report.

# **Note 3. Significant accounting judgments, estimates and assessments** 
In preparing these interim condensed consolidated financial statements, the significant judgments made by management in applying the Group's accounting policies and the key sources of estimation and uncertainty were the same as those applied to the consolidated financial statements for the year ended December 31, 2024.

Estimates and judgments are continually evaluated and are based on historical experience and other factors, including expectation of future events.

# **Note 4. Seasonality** 
To date, we have not experienced pronounced seasonality, but such fluctuations may have been masked by our historical growth and macroeconomic trends, including higher inflation. As the Group continues to grow, including the relative size of our markets, we expect to see additional seasonality effects, especially within the food retail channel, with revenue contribution from this channel tending to be linked with holiday season periods. For example, the Lunar New Year one week celebration occurring in the first quarter of the calendar year has resulted in lower volumes sold in Greater China and the rest of the Asia business compared to the remaining quarterly periods of the year.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

# **Note 5. Segment information** 
***5.1 Revenue, Adjusted EBITDA and EBITDA***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Revenue, Adjusted EBITDA and EBITDA** |  |  |  |  |  |  |
| **Three months ended June 30, 2025** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 118193 | 63185 | 26976 |  |  | 208354 |
| Intersegment revenue | 455 |  |  |  | (455) |  |
| **Total segment revenue** | **118648** | **63185** | **26976** | **—** | **(455)** | **208354** |
| **Adjusted EBITDA** | **24261** | **(2369)** | **(636)** | **(24819)** | **—** | **(3563)** |
| Share-based compensation expense | (515) | (328) | (334) | (2276) | **—** | (3453) |
| Restructuring costs<sup>(1)</sup> | (471) | (585) | (42) | (295) | **—** | (1393) |
| Strategic review of Greater China business<sup>(2)</sup> |  |  | (1378) |  | **—** | (1378) |
| Non-controlling interests |  |  | (35) |  | **—** | (35) |
| **EBITDA** | **23275** | **(3282)** | **(2425)** | **(27390)** | **—** | **(9822)** |
| Finance income and (expenses), net |  |  |  |  |  | (31916) |
| Depreciation and amortization |  |  |  |  |  | (12294) |
| **Loss before tax** |  |  |  |  | **—** | **(54032)** |
| **Three months ended June 30, 2024** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 105541 | 67819 | 28835 |  |  | 202195 |
| Intersegment revenue | 1814 |  |  |  | (1814) |  |
| **Total segment revenue** | **107355** | **67819** | **28835** | **—** | **(1814)** | **202195** |
| **Adjusted EBITDA** | **12638** | **1166** | **(428)** | **(24373)** | **—** | **(10997)** |
| Share-based compensation expense | (501) | (232) | (479) | (2967) | **—** | (4179) |
| Restructuring costs<sup>(1)</sup> | (855) | (769) | (1470) | (120) |  | (3214) |
| Discontinued construction of production facilities<sup>(4)</sup> | (2923) | 277 |  |  |  | (2646) |
| New product launch issue<sup>(5)</sup> |  | (5677) |  |  |  | (5677) |
| **Non-controlling interests** |  |  | (58) |  |  | (58) |
| **EBITDA** | **8359** | **(5235)** | **(2435)** | **(27460)** | **—** | **(26771)** |
| Finance income and (expenses), net |  |  |  |  |  | 10389 |
| Depreciation and amortization |  |  |  |  |  | (12308) |
| **Loss before tax** |  |  |  |  | **—** | **(28690)** |

---

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Six months ended June 30, 2025** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 225858 | 123071 | 56955 |  |  | 405884 |
| Intersegment revenue | 1144 |  |  |  | (1144) |  |
| **Total segment revenue** | **227002** | **123071** | **56955** | **—** | **(1144)** | **405884** |
| **Adjusted EBITDA** | **39797** | **(1240)** | **982** | **(46833)** | **—** | **(7294)** |
| Share-based compensation expense | (983) | (686) | (723) | (4653) |  | (7045) |
| Restructuring costs<sup>(1)</sup> | (471) | (1253) | (42) | (459) |  | (2225) |
| Strategic review of Greater China business<sup>(2)</sup> |  |  | (1378) |  |  | (1378) |
| Closure of production facility<sup>(3)</sup> | 846 |  |  |  |  | 846 |
| Non-controlling interests |  |  | (136) |  |  | (136) |
| **EBITDA** | **39189** | **(3179)** | **(1297)** | **(51945)** | **—** | **(17232)** |
| Finance income and (expenses), net |  |  |  |  |  | (22505) |
| Depreciation and amortization |  |  |  |  |  | (23475) |
| **Loss before tax** |  |  |  |  |  | **(63212)** |
| **Six months ended June 30, 2024** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 215948 | 134786 | 50616 |  |  | 401350 |
| Intersegment revenue | 3778 |  |  |  | (3778) |  |
| **Total segment revenue** | **219726** | **134786** | **50616** | **—** | **(3778)** | **401350** |
| **Adjusted EBITDA** | **27134** | **778** | **(3856)** | **(48257)** | **—** | **(24201)** |
| Share-based compensation expense | (879) | 1027 | (1179) | (5763) | **—** | (6794) |
| Restructuring costs<sup>(1)</sup> | (855) | (769) | (1940) | (71) |  | (3635) |
| Discontinued construction of production facilities<sup>(4)</sup> | (2923) | 1161 |  |  |  | (1762) |
| New product launch issue<sup>(5)</sup> |  | (5677) |  |  |  | (5677) |
| Non-controlling interests |  |  | (102) |  |  | (102) |
| **EBITDA** | **22477** | **(3480)** | **(7077)** | **(54091)** | **—** | **(42171)** |
| Finance income and (expenses), net |  |  |  |  |  | (6988) |
| Depreciation and amortization |  |  |  |  |  | (25321) |
| **Loss before tax** |  |  |  |  |  | **(74480)** |

---

\* Corporate consists of general costs not allocated to the segments.

\*\* Eliminations in 2025 and 2024 refer to intersegment revenue for sales of products from Europe & International to Greater China.

(1) Relates primarily to severance costs as the Group adjusts its organizational structure.

(2) Relates to costs for the strategic review of the Greater China segment.

(3) Relates to reversal of previously recognized exit costs related to closure of the Group's production facility in Singapore.

(4) Relates primarily to non-cash impairments related to discontinued construction of the Group's production facility in Peterborough, UK, and reversal of previously recognized non-cash impairments related to discontinued construction of the Group's production facility in Dallas-Fort Worth, Texas.

(5) Expenses related to a new product launch issue.

**5.2 *Non-current assets by country***

Non-current assets for this purpose consist of property, plant and equipment and right-of-use assets.

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Sweden | 130226 | 114764 |
| China | 97836 | 103791 |
| US | 84795 | 88983 |
| The Netherlands | 33294 | 29349 |
| Other | 1955 | 2867 |
| **Total** | **348106** | **339754** |

---

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

***5.3 Revenue from external customers, broken down by location of the customers***

The Group is domiciled in Sweden. The amount of its revenue from external customers, broken down by location of the customers, is shown in the table below.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| US | 61552 | 66845 | 120346 | 132482 |
| UK | 36788 | 34568 | 68601 | 68594 |
| Germany | 30910 | 28692 | 59803 | 59139 |
| China | 26595 | 28527 | 56234 | 50053 |
| Sweden | 11909 | 11079 | 23219 | 23307 |
| The Netherlands | 6943 | 6125 | 13909 | 13523 |
| Finland | 4638 | 4799 | 9135 | 10406 |
| Other | 29019 | 21560 | 54637 | 43846 |
| **Total** | **208354** | **202195** | **405884** | **401350** |

---

There are no countries that individually make up greater than 10% of total revenue included in "Other".

***5.4 Revenue from external customers, broken down by channel and segment*** 

Revenue from external customers, broken down by channel and segment, is shown in the table below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Three months ended June 30, 2025** | **Europe & International** | **North America** | **Greater China** | **Total** |
| Retail | 93594 | 37219 | 6357 | **137170** |
| Foodservice | 23783 | 25602 | 16821 | **66206** |
| Other | 816 | 364 | 3798 | **4978** |
| **Total** | **118193** | **63185** | **26976** | **208354** |
| **Three months ended June 30, 2024** | **Europe & International** | **North America** | **Greater China** | **Total** |
| Retail | 84669 | 35002 | 2631 | **122302** |
| Foodservice | 20500 | 31173 | 20244 | **71917** |
| Other | 372 | 1644 | 5960 | **7976** |
| **Total** | **105541** | **67819** | **28835** | **202195** |
| **Six months ended June 30, 2025** | **Europe & International** | **North America** | **Greater China** | **Total** |
| Retail | 179034 | 73243 | 10290 | **262567** |
| Foodservice | 45085 | 49113 | 39625 | **133823** |
| Other | 1739 | 715 | 7040 | **9494** |
| **Total** | **225858** | **123071** | **56955** | **405884** |
| **Six months ended June 30, 2024** | **Europe & International** | **North America** | **Greater China** | **Total** |
| Retail | 174876 | 71065 | 5430 | **251371** |
| Foodservice | 40020 | 60286 | 35523 | **135829** |
| Other | 1052 | 3435 | 9663 | **14150** |
| **Total** | **215948** | **134786** | **50616** | **401350** |

---

Other is primarily related to e-commerce, both direct-to-consumer and through third-party platforms.

Revenues of approximately 7% and 10% in the six months ended June 30, 2025 and 2024, respectively, were derived from a single external customer in the foodservice channel. The revenues were attributed to the North America and Greater China segments.

Oatmilk accounted for 91% and 89% of the Group's revenue in the six months ended June 30, 2025 and 2024, respectively.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

# **Note 6. Share-based compensation** 
During the year ended December 31, 2021, in connection with the initial public offering ("IPO"), the Company implemented a new incentive award program, the 2021 Incentive Award Plan ("2021 Plan"). The principal purpose of the 2021 Plan is to attract, retain and motivate selected employees, consultants and members of the Board of Directors through the granting of share-based compensation awards and cash-based performance bonus awards from 2021 and onwards. 69,496,515 ordinary shares have been reserved for grants pursuant to a variety of share-based compensation awards, including, but not limited to, stock options and RSUs. To secure the future delivery of ordinary shares and ADSs under the 2021 Plan, the Company's shareholders resolved to issue 69,496,515 warrants. The right to subscribe for the warrants vests only in the Company. See Note 18 *Equity*.

During the six months ended June 30, 2025, the Company, under the 2021 Plan, granted 1,330,234 RSUs, of which 352,857 were granted to members of key management, including the Executive Officers, and the Board of Directors. 382,555 RSUs vested during the period, of which 154,341 were to key management. The RSUs are accounted for as equity-settled share-based compensation transactions. The RSUs are measured based on the fair market value of the underlying ADSs on the date of grant. The RSUs granted to employees under the 2021 Plan vest in equal installments on each of the first three anniversaries of the date of grant, subject to continued service. The RSUs granted to members of the Company's Board of Directors vest on the date of the next Annual General Meeting of shareholders following the grant date, subject to continued service on the applicable vesting date.

Activity in the Group's RSUs outstanding and related information is as follows:

---

| | | |
|:---|:---|:---|
|  | **Number of RSUs** | **Weighted average grant date fair value ($)** |
| **As of December 31, 2024** | **820170** | **26.00** |
| Granted during the period | 1330234 | 11.10 |
| Forfeited during the period | (37274) | 21.89 |
| Vested during the period | (382555) | 29.30 |
| **As of June 30, 2025** | **1730575** | **13.88** |

---

During the six months ended June 30, 2025, the Company, under the 2021 Plan, granted no new stock options. 196,628 stock options vested during the period, of which 100,326 were to key management. The stock options are accounted for as equity-settled share-based compensation transactions. For stock options granted under the 2021 Plan, the exercise price is equal to the fair value of the ADSs on the date of grant. The stock options granted to participants under the 2021 Plan vest in equal installments on each of the first three anniversaries of the date of grant, subject to continued service. The stock options expire, in relation to each installment under the vesting schedule, five years after vesting, corresponding to a total term of six, seven and eight years for the respective installment.

Activity in the Group's stock options outstanding and related information is as follows:

---

| | | |
|:---|:---|:---|
|  | **Number of stock options** | **Weighted average exercise price ($)** |
| **As of December 31, 2024** | **580314** | **26.40** |
| Forfeited during the period | (45541) | 22.93 |
| Expired during the period | (6119) | 37.24 |
| **As of June 30, 2025** | **528654** | **26.59** |
| Vested and exercisable as of June 30, 2025 | 242662 | 31.64 |

---

The fair value at grant date of the stock options granted during the financial year 2024 was $13.4 for the May 2024 grant date and $9.2 for the November 2024 grant date. The fair value at grant date of the stock options granted during the financial year 2023 was $19.6 for the May 2023 grant date, $21.8 for the July 2023 grant date and $8.6 for the November 2023 grant date. The fair value at grant date of the stock options granted during the financial year 2022 was $29.8 for the May 2022 grant date and $17.2 for the November 2022 grant date. The fair value at grant date of the stock options granted during the financial year 2021 was $124.8 for the May 2021 grant date and $73.4 for the November 2021 grant date. The fair value of the stock options at grant date has been determined using the Black-Scholes option-pricing model, which takes into account the exercise price, the expected term of the stock options, the share price at grant date, expected price volatility of the underlying share, the expected dividend yield, the risk-free interest rate for the term of the stock options and the correlations and volatilities of the peer group companies. The Company does not anticipate paying any cash dividends in the near future and therefore uses an expected dividend yield of zero in the option valuation model.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

Each RSU or stock option entitles the holder to acquire, as determined by the Board of Directors, either twenty ordinary shares, twenty warrants or one ADS in the Company.

Share-based compensation expense was $3.5 million for the three months ended June 30, 2025 (2024: $4.2 million) and $7.0 million for the six months ended June 30, 2025 (2024: $6.8 million).

# **Note 7. Finance income and expenses** 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Interest income | 1085 | 2892 | 2379 | 6375 |
| Other financial income | 155 | 102 | 155 | 204 |
| Net foreign exchange difference | (7763) | (185) | (5565) | 1584 |
| Interest expenses on lease liabilities | (749) | (1487) | (1494) | (3009) |
| Interest expenses on Convertible Notes | (9217) | (8421) | (18092) | (16529) |
| Interest expenses on liabilities to credit institutions | (5978) | (5966) | (11243) | (12155) |
| Fair value changes on derivatives | (504) | 183 | (199) | (745) |
| Fair value changes on Convertible Notes | (8592) | 23894 | 13506 | 23010 |
| Other financial expenses | (353) | (623) | (1952) | (5723) |
| **Total finance income and expenses, net** | **(31916)** | **10389** | **(22505)** | **(6988)** |

---

Interest expense on the Convertible Notes is the nominal coupon rate of 9.25%. Fair value changes on Convertible Notes contains the fair value changes less the coupon rate and changes in credit risk. See Note 13 *Fair value of financial instruments* and Note 21 *Convertible Notes.*

Other financial expenses for the six months ended June 30, 2025 and six months ended June 30, 2024 mainly consists of $1.0 million and $5.0 million, respectively, in transaction costs relating to amendments in the Group's financing arrangements.

See Note 19 *Liabilities to credit institutions* for further details on the Group's credit facilities.

# **Note 8. Income tax** 
Total tax expense for the three and six months ended June 30, 2025 was $1.9 million and $5.3 million respectively. Total tax expense for each of the three and six months ended June 30, 2024 was $1.8 million. The effective tax rate for the three and six months ended June 30, 2025 was 3.5% and 8.3% respectively. The main drivers of the effective tax rate relate to non-recognition of deferred tax assets on tax losses and tax effect relating to foreign exchange effects recognized in other comprehensive income. The effective tax rate for three and six months ended June 30, 2024 was 6.1% and 2.4% respectively, with non-recognition of deferred tax assets on tax losses being the main driver of the effective tax rate. The Group operates in a global environment with significant operations in various jurisdictions outside Sweden. Accordingly, the consolidated income tax rate is a composite rate reflecting the Group's earnings and the applicable tax rates in the various jurisdictions where the Group operates, and whether or not deferred tax assets are able to be recognized.

The Group is, as of January 1, 2025 in scope of the OECD Pillar Two Model Rules ("P2 Rules"). The legislation is effective for the Group's financial year beginning January 1, 2025. The P2 Rules have been enacted (or substantively enacted) in most jurisdictions in which the Group operates, including Sweden. Although no material exposure arising from Pillar Two has been identified to date, material Pillar Two impacts to the Group's tax expense remain possible.

In May 2023, the IASB amended IAS 12 Income Taxes to include a mandatory temporary exception from recognizing or disclosing deferred taxes relating to the P2 Rules. The Group has applied this mandatory exception which did not have a material impact to the consolidated financial statements.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

# **Note 9. Intangible assets** 
A summary of the intangible assets as at June 30, 2025 and December 31, 2024 is as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Goodwill** | **Capitalized<br>software** | **Other<br>intangible<br>assets** | **Ongoing<br>development<br>costs** | **Total** |
| **Cost** |  |  |  |  |  |
| **At December 31, 2024** | **107241** | **14673** | **8017** | **1213** | **131144** |
| Additions |  | (24) | 493 | 419 | 888 |
| Reclassification |  |  | 112 | (112) |  |
| Exchange differences | 17343 | 2369 | 1178 | 194 | 21084 |
| **At June 30, 2025** | **124584** | **17018** | **9800** | **1714** | **153116** |
| **Accumulated amortization** |  |  |  |  |  |
| **At December 31, 2024** | **—** | **(10083)** | **(4853)** | **—** | **(14936)** |
| Amortization charge |  | (1188) | (891) |  | (2079) |
| Exchange differences |  | (1718) | (755) |  | (2473) |
| **At June 30, 2025** | **—** | **(12989)** | **(6499)** | **—** | **(19488)** |
| **Cost, net accumulated amortization** |  |  |  |  |  |
| **At December 31, 2024** | **107241** | **4590** | **3164** | **1213** | **116208** |
| **At June 30, 2025** | **124584** | **4029** | **3301** | **1714** | **133628** |

---

Amortization expense for the three months ended June 30, 2025 was $1.1 million (2024: $1.1 million). Amortization expense for the six months ended June 30, 2025 was $2.1 million (2024: $2.1 million).

# **Note 10. Property, Plant and Equipment** 
A summary of property, plant, and equipment as at June 30, 2025 and December 31, 2024 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Land and<br>buildings** | **Plant and<br>machinery** | **Construction<br>in progress** | **Total** |
| **Cost** |  |  |  |  |
| **At December 31, 2024** | **104811** | **286153** | **54315** | **445279** |
| Additions | 120 | 2291 | 4116 | 6527 |
| Disposals<sup>(1)</sup> | (6826) | (25581) | (426) | (32833) |
| Reclassifications | 1930 | 13678 | (15608) |  |
| Exchange differences | 8967 | 15660 | 4847 | 29474 |
| **At June 30, 2025** | **109002** | **292201** | **47244** | **448447** |
| **Accumulated depreciation and impairment** |  |  |  |  |
| **At December 31, 2024** | **(23376)** | **(109525)** | **(18179)** | **(151080)** |
| Depreciation charge | (3152) | (12662) |  | (15814) |
| Disposals<sup>(1)</sup> | 6826 | 25005 | 426 | 32257 |
| Exchange differences | (2270) | (6703) | (272) | (9245) |
| **At June 30, 2025** | **(21972)** | **(103885)** | **(18025)** | **(143882)** |
| **Cost, net accumulated depreciation and impairment** |  |  |  |  |
| **At December 31, 2024** | **81435** | **176628** | **36136** | **294199** |
| **At June 30, 2025** | **87030** | **188316** | **29219** | **304565** |

---

(1) Relates primarily to disposed assets due to the closure of the Group's production facility in Singapore.

Depreciation expense for the three months ended June 30, 2025 was $8.4 million (2024: $8.7 million). Depreciation expense for the six months ended June 30, 2025 was $15.8 million (2024: $17.3 million).

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

# **Note 11. Leases** 
Lease terms for production facilities are generally between 10 and 20 years, and lease terms for other properties (i.e., offices) are generally between one and 15 years. Lease terms for production equipment are generally between one and five years. The Group also has leases with a shorter lease term than 12 months and leases pertaining to assets of low value, such as office equipment. For these, the Group has chosen to apply the exemption rules in IFRS 16 Leases, meaning the value of these contracts is not part of the right-of-use asset or lease liability.

Below is the roll-forward of lease right-of-use assets:

---

| | | | |
|:---|:---|:---|:---|
|  | **Land and<br>buildings** | **Plant and<br>machinery** | **Total** |
| **Cost** |  |  |  |
| **At December 31, 2024** | **56089** | **28178** | **84267** |
| Increases | 1051 | 173 | 1224 |
| Decreases | (1362) | (1467) | (2829) |
| Exchange differences | 2974 | 1980 | 4954 |
| **At June 30, 2025** | **58752** | **28864** | **87616** |
| **Accumulated depreciation** |  |  |  |
| **At December 31, 2024** | **(24917)** | **(13795)** | **(38712)** |
| Depreciation | (3582) | (2000) | (5582) |
| Decreases | 1262 | 1479 | 2741 |
| Exchange differences | (1263) | (1259) | (2522) |
| **At June 30, 2025** | **(28500)** | **(15575)** | **(44075)** |
| **Cost, net accumulated depreciation** |  |  |  |
| **At December 31, 2024** | **31172** | **14383** | **45555** |
| **At June 30, 2025** | **30252** | **13289** | **43541** |

---

Depreciation expense for the three months ended June 30, 2025 was $2.9 million (2024: $2.6 million). Depreciation expense for the six months ended June 30, 2025 was $5.6 million (2024: $5.9 million)

Below is the maturity analysis of lease liabilities:

---

| | |
|:---|:---|
| **Lease liabilities** | **June 30, 2025** |
| **Maturity Analysis** |  |
| Less than 3 months | 3466 |
| Between 3 months and 1 year | 10398 |
| Between 1 and 2 years | 11619 |
| Between 2 and 5 years | 15286 |
| After 5 years | 13799 |
| **Total lease commitments** | **54568** |
| Impact of discounting remaining lease payments | (11587) |
| **Total lease liabilities at June 30, 2025** | **42981** |
| **Lease liabilities included in the condensed consolidated<br>statement of financial position at June 30, 2025** |  |
| Non-current | 29508 |
| Current | 13473 |
| **Total** | **42981** |

---

The Group has the following lease agreements, which had not commenced as of June 30, 2025, but to which the Group is committed:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•One lease agreement regarding production equipment in Ma'anshan, China, under which the Group's obligations collectively amount to $3.5 million for a term of six years.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

# **Note 12. Other non-current receivables** 

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Promissory note | 26399 | 24867 |
| Long-term prepaid expenses | 14059 | 14634 |
| Deposits | 1058 | 1024 |
| Derivatives |  | 125 |
| Other receivables | 3624 | 3681 |
| **Total** | **45140** | **44331** |

---

The promissory note is part of the purchase price from selling the manufacturing facilities in Ogden, Utah and Dallas-Fort Worth, Texas during 2023. The note has a maturity date of May 31, 2028. The nominal interest rate is 8% for the first year and then increases by 200 basis points each year. The interest is capitalized semi-annually, and the effective interest rate is 12.56%.

Long-term prepaid expenses consist primarily of a credit toward future use of shared assets at the manufacturing facility in Ogden.

# **Note 13. Fair value of financial instruments** 
This note explains the judgments and estimates made in determining the fair values of the financial instruments that are recognized and measured at fair value in the financial statements. To provide an indication about the reliability of the inputs used in determining fair value, the Group has classified its financial instruments into the three levels prescribed under the accounting standards.

**Level 1:** The fair value of financial instruments traded in active markets (such as publicly traded derivatives and equity securities) is based on quoted market prices at the end of the reporting period. The quoted market price used for financial assets held by the Group is the current bid price. These instruments are included in Level 1.

**Level 2:** The fair value of financial instruments that are not traded in an active market (for example, over-the-counter derivatives) is determined using valuation techniques, which maximize the use of observable market data and rely as little as possible on entity-specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2.

Specific valuation techniques used in Level 2 to value financial instruments include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•for foreign currency forwards, the present value of future cash flows based on the forward exchange rates at the balance sheet date

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•for interest rate caps – option pricing models (e.g. Black-Scholes model)

**Level 3:** If one or more of the significant inputs is not based on observable market data, the instrument is included in Level 3. This is the case for unlisted equity securities.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

---

| | | | |
|:---|:---|:---|:---|
| **Recurring fair value measurements at June 30, 2025** | **Level 1** | **Level 2** | **Level 3** |
| **Financial assets** |  |  |  |
| Derivatives (part of Other current receivables) |  | 4 |  |
| **Total financial assets** |  | **4** | **—** |
| **Financial liabilities** |  |  |  |
| Convertible Notes |  |  | 328981 |
| Derivatives (part of Other current liabilities) |  | 58 |  |
| **Total financial liabilities** |  | **58** | **328981** |
| **Recurring fair value measurements at December 31, 2024** | **Level 1** | **Level 2** | **Level 3** |
| **Financial assets** |  |  |  |
| Derivatives (part of Other non-current receivables) |  | 125 |  |
| **Total financial assets** |  | **125** | **—** |
| **Financial liabilities** |  |  |  |
| Convertible Notes |  |  | 324395 |
| Derivatives (part of Other current liabilities) |  | 2 |  |
| **Total financial liabilities** |  | **2** | **324395** |

---

There were no transfers between the levels during the six months ended June 30, 2025 and the year ended December 31, 2024.

The carrying amount of the promissory note, is a reasonable approximation of fair value since the transaction was closed on March 1, 2023, and there have been no significant changes to credit risk or market rates during the period March 1, 2023 until June 30, 2025. See Note 12 *Other non-current receivables.*

The carrying amount of non-current liabilities to credit institutions in the Group is a reasonable approximation of fair value since the interest rate is variable and there have been no significant changes to credit risk since issued on April 18, 2023. See Note 19 *Liabilities to credit institutions.*

The carrying amount of current liabilities to credit institutions and other financial instruments in the Group is a reasonable approximation of fair value since they are short-term, and the discount effect is not significant.

***Convertible Notes*** 

---

| | |
|:---|:---|
|  | **Convertible Notes** |
| **At January 1, 2024** | **323528** |
| Fair value changes (including interest expenses) recognized in the consolidated statement of operations | 867 |
| **At December 31, 2024** | **324395** |
| Fair value changes (including interest expenses) recognized in the consolidated statement of operations | 4586 |
| **At June 30, 2025** | **328981** |

---

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Carrying amount | 328981 | 324395 |
| Amount the Company is contractually obligated to pay to holders of the Convertible Notes at maturity | 546842 | 546842 |
| **Difference between carrying amount and the amount the Company is contractually obligated to pay to holders of Convertible Notes at maturity** | **(217861)** | **(222447)** |

---

The Group determines the amount of fair value changes which are attributable to credit risk by first determining the changes due to market conditions which give rise to market risk, and then deducting those changes from the total change in fair value of the Convertible Notes. Market conditions which give rise to market risk include changes in the benchmark interest rate. Fair value movements on the conversion option embedded derivative are included in the assessment of market risk fair value changes.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

The fair value of the instrument in its entirety has been determined by using a combination of a Monte Carlo simulation and a discounted cash flow analysis.

The following table lists the key inputs and assumptions used in the valuation model as of June 30, 2025:

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Conversion price per ADS ($)<sup>(1)</sup> | 27.2-28.2 | 27.2-37.8 |
| ADS price at valuation date ($) | 11.87 | 13.26 |
| Expected price volatility of the Company ADS (%) | 70.00 | 70.00 |
| Risk-free interest rate (%) | 3.70 | 4.30 |
| Market interest rate (%) | 21.20 | 20.00 |

---

(1) The U.S. Notes (as defined below) are convertible at the option of each holder at a conversion price of $27.20 per ADS, subject to customary anti-dilution adjustments. The HH Notes (as defined below) are convertible at the option of each holder at a conversion price of $28.20 per ADS, subject to customary anti-dilution adjustments. The Swedish Notes (as defined below) are convertible at the option of each holder at a conversion price of $1.36 per ordinary share, subject to customary anti-dilution adjustments. For further details on the Convertible Notes , see Note 21 *Convertible Notes.*

The market interest rate has been assessed based on the observed range of yields on corporate bonds with comparable terms and comparable credit ratings to that of the Group.

The following table shows the impact of the key inputs and assumptions on the fair value of the Convertible Notes:

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| ADS price decrease 30% | 313605 | 303849 |
| ADS price increase 30% | 347245 | 346372 |
| Volatility decrease 10 percentage points | 325102 | 319311 |
| Volatility increase 10 percentage points | 331801 | 329108 |
| Risk-free interest rate decrease 1 percentage point | 328413 | 323810 |
| Risk-free interest rate increase 1 percentage point | 329552 | 324954 |
| Market interest rate decrease 1 percentage point | 336928 | 333154 |
| Market interest rate increase 1 percentage point | 321306 | 315973 |

---

For further information on the Convertible Notes, see Note 21 *Convertible Notes*.

# **Note 14. Inventories** 

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Raw materials and consumables | 12551 | 12565 |
| Finished goods | 53300 | 53037 |
| **Total** | **65851** | **65602** |

---

Inventories recognized as an expense for the three months ended June 30, 2025 amounted to $133.2 million (2024: $135.2 million). Inventories recognized as an expense for the six months ended June 30, 2025 amounted to $260.8 million (2024: $273.0 million). The expenses were included in cost of goods sold.

Write-downs of inventories to net realizable value for the three months ended June 30, 2025 amounted to $0.8 million (2024: $0.2 million). Write-downs of inventories to net realizable value for the six months ended June 30, 2025 amounted to $4.4 million (2024: $0.5 million). The write-downs were recognized as an expense for each period and included in cost of goods sold.

# **Note 15. Trade receivables** 

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Trade receivables | 102955 | 104144 |
| Less: allowance for expected credit losses | (358) | (778) |
| **Trade receivables—net** | **102597** | **103366** |

---

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

Carrying amounts, by currency, for the Group's trade receivables are as follows:

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| EUR | 32129 | 31660 |
| GBP | 24654 | 19670 |
| USD | 23590 | 29931 |
| CNY | 11737 | 13616 |
| SEK | 2876 | 2701 |
| Other | 7611 | 5788 |
| **Total** | **102597** | **103366** |

---

The maximum exposure to credit risk on the date of the statement of financial position is the carrying amounts according to the above.

# **Note 16. Other current receivables** 

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Value added tax | 7961 | 6169 |
| Advance payments to vendors | 1673 | 1158 |
| Short-term derivatives | 4 |  |
| Other | 8330 | 8411 |
| **Total** | **17968** | **15738** |

---

**Note 17. Cash and cash equivalents**

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Short-term deposits |  | 40000 |
| Cash at bank and on hand | 67931 | 58923 |
| **Total** | **67931** | **98923** |

---

In 2024, short-term deposits were time deposits and structured deposits, with maturities of one to three months.

# **Note 18. Equity** 
***Share capital and Treasury shares***

In May 2021, the shareholders resolved to issue 69,496,515 warrants to secure the future delivery of ordinary shares under the 2021 Plan. During May 2025, the Company exercised 8,452,360 warrants (May 2024: 3,667,255 warrants, May 2023: 2,882,164 warrants, May 2022: 650,000 warrants). As of June 30, 2025 and December 31, 2024, there were 53,844,736 and 62,297,096 warrants outstanding, respectively.

Upon exercise of the warrants in May 2025, 8,452,360 ordinary shares were allotted and issued, and 7,651,100 ordinary shares were converted to American Depositary Shares to be delivered to participants under the 2021 Incentive Award Plan related to the vesting of the May 2022, May 2023 and May 2024 grants. The remaining balance is held as treasury shares to enable the Company's timely delivery of ordinary shares upon the exercise of outstanding stock options and to meet future vesting of the RSUs.

During the six months ended June 30, 2025, 4,480 treasury shares were sold to cover fees in connection with the ADS Ratio Change.

As of June 30, 2025 and December 31, 2024, 606,215,420 and 598,559,840 ordinary shares, respectively were outstanding, and the par value per share was $0.00018 (SEK 0.0015). The Company had 1,213,360 and 416,580 treasury shares as of June 30, 2025 and December 31, 2024, respectively.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

***Other contributed capital*** 

As of June 30, 2025 and December 31, 2024 other contributed capital of $1,628.0 million consists of share premium, shareholders contribution and proceeds from warrant issues.

***Other reserves*** 

As of June 30, 2025 other reserves of $(222.1) million consists of fair value reserve of $(72.7) million related to fair value gains and losses on the Convertible Notes attributable to changes in the Group's credit risk, and foreign currency translation reserve of $(149.4) million primarily related to the exchange differences occurring from the translation of foreign operations in another currency than the reporting currency of the Group (USD).

As of December 31, 2024 other reserves of $(274.2) million consists of fair value reserve of $(72.7) million related to fair value gains and losses on the Convertible Notes attributable to changes in the Group's credit risk, and foreign currency translation reserve of $(201.5) million primarily related to the exchange differences occurring from the translation of foreign operations in another currency than the reporting currency of the Group (USD).

***Accumulated deficit*** 

As of June 30, 2025 and December 31, 2024, accumulated deficit of $(1,310.6) million and $(1,249.3) million, respectively, consists of accumulated losses and share-based compensation.

***Non-controlling interest***

On July 27, 2023, one of the Group's subsidiaries in China carried out a share issue. Prior to the share issue the Group owned 100 percent of the share capital in the subsidiary. Xiangpiaopiao Food Co., Ltd. subscribed for a part of the new issued shares and owns 40 percent of the share capital after the transaction, whereas the Group recognized a non-controlling interest. As of June 30, 2025 and December 31, 2024, non-controlling interests amounted to $1.3 million and $1.4 million, respectively.

**Note 19. Liabilities to credit institutions**

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Non-current liabilities to credit institutions | 115746 | 116216 |
| Current liabilities to credit institutions | 4899 | 5757 |
| **Total** | **120645** | **121973** |

---

As of June 30, 2025 and December 31, 2024, the Liabilities to credit institutions balance amounted to $120.6 million and $122.0 million, respectively, and was related to outstanding amounts under the TLB Credit Agreement (as defined below) and the EIF Facility (as defined below).

The European Investment Fund guaranteed three-year term loan facility with Svensk Exportkredit (the "EIF Facility") was entered into in October 2019. In October 2022, the EIF Facility was amended to extend the term for another three years, with a maturity date in October 2025. The loan facility and interest margin remain unchanged. As of June 30, 2025 and December 31, 2024, the Group had €0.6 million (equivalent of $0.7 million) and €1.3 million (equivalent of $1.3 million), respectively, outstanding on the EIF Facility, including accrued interest.

In April 2023, the Company entered into a Term Loan B Credit Agreement (the "TLB Credit Agreement") with, amongst others, Silver Point Finance LLC as Syndication Agent and Lead Lender, J.P. Morgan SE, as Administrative Agent and Wilmington Trust (London) Limited as Security Agent, including a term loan facility of $130 million borrowed by Oatly AB. The term of the TLB Credit Agreement is five years from the funding date of the term loan facility, and the term loan facility is subject to 1% amortization per annum paid in quarterly installments. Borrowings carry an interest rate of Term SOFR (with floor of 2.50%) plus 7.5% or Base Rate (with floor of 3.50%) plus 6.5%. The TLB Credit Agreement, contains ongoing covenants such as minimum EBITDA, total net leverage ratio and liquidity requirements. The TLB Credit Agreement also contains certain negative covenants, including but not limited to restrictions on indebtedness, limitations on liens, fundamental changes covenant, asset sales covenant, and restricted payments covenant. The debt under the TLB Credit Agreement ranks pari passu with, and shares in the same security and guarantees from the Group as the EIF Facility and the SRCF Agreement by way of the Intercreditor Agreement.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

As of June 30, 2025 and December 31, 2024, the Group had $119.9 million and $120.7 million, respectively, outstanding on the TLB Credit Agreement, including accrued interest and net after original issue discount and transaction costs.

In April 2023, the SRCF Agreement was amended and restated whereby, among other things, (i) the term of the SRCF Agreement was reset to three years and six months, with a one year uncommitted extension option, (ii) the lender group under the SRCF Agreement was reduced to JP Morgan SE, BNP Paribas SA, Bankfilial Sverige, Coöperatieve Rabobank U.A. and Nordea Bank Abp, filial i Sverige and the commitments under the SRCF Agreement were reduced to SEK 2,100 million (equivalent of $192.1 million), with an uncommitted incremental revolving facility option of up to SEK 500 million (equivalent of $45.7 million), (iii) the initial margin was reset at 4.00% p.a., (iv) the tangible solvency ratio, minimum EBITDA, minimum liquidity and total net leverage ratio financial covenants were reset, (v) the existing negative covenants were amended to further align with those included in the TLB Credit Agreement, including in relation to incurrence of indebtedness, and (vi) the debt under the SRCF Agreement ranks pari passu with, and shares in the same security and guarantees from the Group as, the EIF Facility and the TLB Credit Agreement by way of the Intercreditor Agreement. As of June 30, 2025 and December 31, 2024, the Group had no utilized loan amounts under the amended SRCF Agreement.

In May 2023, (i) the SRCF Agreement was amended pursuant to an amendment letter to, among other things, ensure that the Convertible Notes constitute "PIPE Financing" under and as defined in the SRCF Agreement and (ii) the TLB Credit Agreement was amended pursuant to an amendment agreement to, among other things, ensure that the Convertible Notes constitute "Convertible Bonds" under and as defined in the TLB Credit Agreement. See Note 21 *Convertible Notes* for more information on the Company's Convertible Notes.

On February 14, 2024, the Sustainable Revolving Credit Facility Agreement and the Term Loan B Credit Agreement were amended and restated to, among other things, (i) reset the financial covenant levels applying to the minimum EBITDA (including separate testing of the Group's Europe & International EBITDA, the definition of which has subsequently been corrected by way of subsequent amendment), minimum liquidity and total net leverage ratio financial covenants and, in relation to the Sustainable Revolving Credit Facility Agreement, the tangible solvency ratio financial covenant, (ii) revise certain financial definitions to permit additional adjustments for the purpose of the calculation of the financial covenants and (iii) provide certain flexibility for disposals of assets relating to the Group's production facilities in Dallas Fort Worth, Texas, United States of America and Peterborough, United Kingdom. In addition, the existing draw-stop level for the Sustainable Revolving Credit Facility Agreement, which requires that a certain amount of such facility remains undrawn for as long as the last twelve months' ("LTM") consolidated EBITDA of the Group is negative, was increased from $50 million to $100 million, and the original 24 months' non-call/make-whole period applying under the Term Loan B Credit Agreement was reset to apply for the 18 months following the amendment effective date (for the avoidance of doubt, the subsequent 12 months' prepayment fee period still applies after the end of such 18-month period).

Under the amended Sustainable Revolving Credit Facility Agreement and Term Loan B Credit Agreement, the total net leverage ratio financial covenant, tested in respect of the LTM period ending on each quarter date, will start to apply in respect of the LTM period ending on 31 December 2026 and the applicable financial covenant level will be 4.50:1, stepping down to 3.50:1 for each LTM period ending in 2027 and to 3.00:1 for each LTM period in 2028. The reset quarterly tangible solvency ratio financial covenant level applying under the amended Sustainable Revolving Credit Facility Agreement is 30%.

On February 14, 2024, the EIF Facility was amended and restated to, where and to the extent applicable, implement equivalent amendments as those made to the Sustainable Revolving Credit Facility Agreement on February 14, 2024.

On February 11, 2025, the SRCF Agreement and TLB Credit Agreement were amended and restated to, among other things, (i) reset certain financial covenant levels applying to the minimum liquidity financial covenant, (ii) revise certain financial definitions to permit additional adjustments for the purpose of the calculation of certain financial covenants, including in relation to certain costs relating to the discontinuance of certain of the Group's manufacturing facilities and (iii) provide certain flexibility for disposals of assets relating to the relevant manufacturing facilities.

The amended SRCF Agreement and TLB Credit Agreement impose limitations on drawdowns under the SRCF Agreement (other than under ancillary facilities, such as overdraft facilities and bank guarantees, which are exempted from these limitations) based on the last four quarters' consolidated EBITDA of the Group, where, if last four quarters' consolidated EBITDA of the Group is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) less than $0, $0 may be drawn; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) equal to or greater than $75 million, the full amount of the existing facility may be drawn,

with interim steps in between, and increases requiring improved performance for two consecutive four quarter periods and reductions requiring decreased performance for one four quarter period.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

On February 11, 2025, the EIF Facility was amended and restated to, where and to the extent applicable, implement<br>equivalent amendments as those made to the Sustainable Revolving Credit Facility Agreement on February 11, 2025.

On March 19, 2025, Oatly Shanghai Co., Ltd. entered into a new RMB 30 million (equivalent of $4.2 million) working capital credit facility with China Merchants Bank Co., Ltd. Shanghai Branch (the "CMB Credit Facility"). Individual utilizations under the CMB Credit Facility are subject to the lender's approval. The CMB Credit Facility is available for one year, is unsecured, and includes creditor protection in the form of, among other things, representations, covenants (including negative pledge, restrictions on borrowings, investments and dispositions by Oatly Shanghai Co., Ltd., distributions by Oatly Shanghai Co., Ltd. and entry into transactions with its affiliates) and events of default. As of June 30, 2025, the Group had no utilized loan amounts under the amended CMB Credit Facility.

For more information on the Group's credit facilities, see Item 2. *"Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources"*.

***Currency risk (transaction risk)***

The TLB Credit Agreement is denominated in USD and the borrower within the Group is Oatly AB with a functional currency of SEK. The Group is therefore exposed to currency risk SEK/USD and if the rate would increase/decrease by 10% the impact on loss before tax for the six months ended June 30, 2025, would be $11.7 million.

***Interest rate risk*** 

The Group is exposed to interest rate risk that arises from the term loan that carries an interest of Term SOFR with a floor of 2.5%. To manage the risk the Group has entered into interest rate caps for the full amount of the term loan of $130 million. The cap is 4.6% and has a maturity of 3 years (April 2026). The effect from increase in basis points is limited due to the cap that economically hedges the TLB Credit Agreement. If variable interest increased by 300 basis points the impact on loss before tax for the six months ended June 30, 2025, would be $0.2 million. If variable interest decreased by 300 basis points the impact on loss before tax for the six months ended June 30, 2025, would be $1.1 million, taking into account the floor of 2.5% in the term loan.

# **Note 20. Provisions** 

---

| | |
|:---|:---|
|  | **Restructuring** |
| **At December 31, 2024** | **33061** |
| Charged to the consolidated statement of operations: |  |
| &nbsp;&nbsp;- Additional provisions recognized | 2054 |
| &nbsp;&nbsp;- Unwinding of discount effect | 303 |
| &nbsp;&nbsp;- Reversal of non-utilized amounts | (1636) |
| Amounts used during the year | (8235) |
| Charged to other comprehensive loss: |  |
| &nbsp;&nbsp;- Exchange differences | 1902 |
| **At June 30, 2025** | **27449** |
| Non-current | 9317 |
| Current | 18132 |

---

#  ***Restructuring*** 
The restructuring provisions recorded in 2024 was principally related to decommissioning and other exit costs for the closure of the production facility in Singapore. The costs relating to the closure of the facility are expected to be paid throughout the coming 2 years. The Group also recorded provisions related to organizational restructuring. The main part of the organizational restructuring plan was drawn up and announced to the employees during 2024, with some additional parts being announced and recorded as expense during 2025.

During the six months ended June 30, 2025, the Group had $5.1 million in cash outflows relating to organizational restructuring and $3.1 million in cash outflows relating to the closure of the production facility in Singapore.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

**Note 21. Convertible Notes**

On March 23, 2023 and April 18, 2023, the Company issued $300 million aggregate principal amount of 9.25% Convertible Senior PIK Notes due 2028 (the notes issued on March 23, 2023, the "U.S. Notes" and the notes issued on April 18, 2023, the "Swedish Notes" and, together with the U.S. Notes, the "Original Convertible Notes" and the Original Convertible Notes, together with the HH Notes (as defined below), the "Convertible Notes"). The U.S. Notes and the Swedish Notes have substantially identical economic terms.

Certain of the Company's existing shareholders, Nativus Company Limited, Verlinvest S.A. ("Verlinvest") and Blackstone Funds, purchased $200.1 million aggregate principal amount of the Swedish Notes and other institutional investors purchased $99.9 million aggregate principal amount of the U.S. Notes. The investors paid an aggregate purchase price of $291 million, reflecting an original issue discount of 3%.

The Convertible Notes bear interest at a rate of 9.25% per annum, payable semi-annually in arrears in cash or in payment-in-kind, at the Company's option, on April 15 and October 15 of each year, beginning on October 15, 2023. The Convertible Notes will mature on September 14, 2028, unless earlier converted by the holders or required to be converted, repurchased or redeemed by the Company. The Original Convertible Notes were convertible at the option of each holder at an initial conversion price of $2.41 per ordinary share or per ADS, subject to customary anti-dilution adjustments and conversion rate resets. On March 23, 2024, the conversion price of the Original Convertible Notes was reset to $1.81 in accordance with the terms thereof.

On February 18, 2025, the Company completed a ratio change whereby the ratio of the Company's ADSs to ordinary shares was changed from one ADS representing one ordinary share to one ADS representing twenty ordinary shares (the "ADS Ratio Change"). As a result of the ADS Ratio Change, the conversion price of the U.S. Notes was proportionately adjusted from $1.81 to $36.20. The conversion price of the U.S. Notes was reset again on March 23, 2025, to $27.20.

Because the Swedish Notes are convertible into ordinary shares rather than ADSs, the ADS Ratio Change did not affect the conversion price and conversion rate of the Swedish Notes. In order to ensure that the holders of the Swedish Notes remain in the same economic position as before the ADS Ratio Change and to preserve economic equivalency of the Swedish Notes with the U.S. Notes and the HH Notes, the Company, in accordance with the terms and conditions of the Swedish Notes (the "Swedish Terms"), will interpret the definition of "Daily VWAP" therein to assume the trading price of 1/20 of an ADS. The conversion price of the Swedish Notes was reset again on March 23, 2025, to $1.36.

The Company may require conversion of the Convertible Notes if the last reported sale price of the Company's ADSs equals or exceeds 200% of the applicable conversion price (in the case of the Swedish Notes, the definition of "Last Reported Sale Price" is interpreted to equal 1/20 of an ADS) on any 45 trading days during any 90 consecutive day period beginning on or after the third anniversary of the issuance of the U.S. Notes (with respect to the U.S. Notes and the HH Notes) and the Swedish Notes (with respect to the Swedish Notes).

On April 18, 2023, the Company, Oatly AB, Oatly Inc. and other parties entered into an intercreditor agreement (the "Intercreditor Agreement") which includes customary ranking, enforcement and turnover provisions intended to govern the relationship between the creditor groups and which affects the Convertible Notes.

On May 9, 2023, the Company entered into an agreement with an affiliate of Hillhouse Investment Management Ltd. ("Hillhouse") to sell an additional $35 million in Convertible Senior PIK Notes due 2028 (the "HH Notes"), resulting in approximately $34 million in financing after reflecting an original issue discount of 3%. The economic terms of the HH Notes are substantially identical to the economic terms of the U.S. Notes, except (i) that the HH Notes were convertible at Hillhouse's option at an initial conversion price of $2.52 per ADS, representing an approximate 17% premium to the last reported sale price of the Company's ADSs on the Nasdaq Global Market on May 8, 2023, and (ii) with respect to the specified prices in connection with the conversion rate resets of the HH Notes. On March 23, 2024, the conversion price of the HH Notes was reset to $1.89 in accordance with the terms thereof. As a result of the ADS Ratio Change, the conversion price of the HH Notes was proportionately adjusted from $1.89 to $37.80. The conversion price of the HH Notes was reset again on March 23, 2025, to $28.20.

In addition, on May 9, 2023, one of the existing holders of Swedish Notes and an affiliate of one of the Company's shareholders, Verlinvest, agreed to sell and Hillhouse agreed to purchase from Verlinvest $15 million aggregate principal amount of Swedish Notes (the "Resale Notes"). The purchase and sale of the HH Notes and the Resale Notes closed on May 31, 2023. The HH Notes are also subject to the Intercreditor Agreement.

The terms of the Convertible Notes contain covenants limiting the Company's ability to incur additional debt other than certain debt permitted under the TLB Credit Agreement, issue preferred stock, and incur convertible debt or subordinated debt, in each case without the consent of the holders of a majority of the Convertible Notes (as determined pursuant to the terms of the applicable Convertible Notes).

For details on the fair value on Convertible Notes, see Note 13 *Fair value of financial instruments.*

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

# **Note 22. Accrued expenses** 

---

| | | |
|:---|:---|:---|
|  | **June 30, 2025** | **December 31, 2024** |
| Accrued variable consideration | 31849 | 24549 |
| Accrued personnel expenses | 25320 | 24284 |
| Accrued production expenses | 11617 | 12701 |
| Accrued logistic expenses | 10734 | 10762 |
| Accrued marketing and sales expenses | 9620 | 9218 |
| Other accrued expenses | 23535 | 22205 |
| **Total** | **112675** | **103719** |

---

**Note 23. Related party disclosures**

***Share-based compensation to related parties***

Information about share-based compensation to related parties is found in Note 6 *Share-based compensation*.

***Transactions with related parties*** 

On April 18, 2023 the Company issued Convertible Notes to related parties, Nativus Company Limited and Verlinvest, with a fair value of $174.0 million. As of June 30, 2025, the fair value of the outstanding Convertible Notes to related parties amounted to $161.3 million. The Convertible Notes were issued with the terms and conditions described in Note 21 *Convertible Notes.*

**Note 24. Loss per share**

The Company calculates loss per share by dividing loss for the period attributable to the shareholders of the parent by the weighted average number of ordinary shares outstanding during the period (net of treasury shares).

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Loss for the year, attributable to the shareholders of the parent | (55911) | (30384) | (68341) | (76183) |
| Weighted average number of ordinary shares | 601195247 | 596242505 | 599884824 | 595654647 |
| **Basic and diluted loss per share, U.S. $** | **(0.09)** | **(0.05)** | **(0.11)** | **(0.13)** |
| Weighted average number of ADS (1 ADS representing 20 ordinary shares)<sup>(1)</sup> | 30059762 | 29812125 | 29994241 | 29782732 |
| **Basic and diluted loss per ADS, U.S. $** | **(1.86)** | **(1.02)** | **(2.28)** | **(2.56)** |

---

(1) On February 18, 2025, the Company completed a ratio change whereby the ratio of its ADSs to ordinary shares was changed from one ADS representing one ordinary share to one ADS representing twenty ordinary shares. The weighted average number of ADSs has been calculated by dividing the weighted average number of shares by 20, even though the actual number of outstanding ADSs is lower since not all of the ordinary shares in the Company are represented by ADSs. For further details on the ADS Ratio Change, see Note 2 *Summary of accounting policies*.

Potential dilutive securities that were not included in the diluted loss per share calculations because they would be anti-dilutive were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Restricted stock units representing ordinary shares | 34611500 | 17680096 | 34611500 | 17680096 |
| Stock options representing ordinary shares | 10573080 | 15285292 | 10573080 | 15285292 |
| Convertible Notes<sup>(1)</sup> | 400616344 | 400616344 | 400616344 | 400616344 |

---

(1) The number of potential dilutive shares from the Convertible Notes are calculated assuming the most advantageous conversion price from the standpoint of the holder and assuming all capitalized interest at maturity will be settled with shares or ADSs. For further details on the Convertible Notes and the conversion price reset mechanism, see Note 21 *Convertible Notes*.

------

**Notes to the interim condensed consolidated financial statements**

(in thousands of U.S. dollars unless otherwise stated)

# **Note 25. Commitments and Contingencies** 

##  ***Commitments*** 

## *Minimum purchase commitments* 
The Group has several supplier contracts primarily for production and packaging services where minimum purchase commitments exist in the contract terms. The commitments are associated with contracts that are enforceable and legally binding and that specify significant terms, including fixed or minimum services to be purchased and fixed, minimum or variable price provisions. For the six months ended June 30, 2025, volume adjustments related to co-packer arrangements in Europe & International and North America resulted in volume shortfall expenses of $5.6 million. The shortfall expenses are presented in cost of goods sold in the consolidated statement of operations.

## *Leases* 
The future cash outflows relating to leases that have not yet commenced are disclosed in Note 11 *Leases.* 

------

# **Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations** 
**Special Note Regarding Forward-Looking Statements**

This Report on Form 6-K (the "Report") contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. These forward-looking statements are contained principally in this Item 2. *"Management's Discussion and Analysis of Financial Condition and Results of Operations."* These statements relate to events that involve known and unknown risks, uncertainties and other factors, including those listed under Item 3.D. *"Risk Factors"* of our Annual Report on Form 20-F for the year ended December 31, 2024 (our "2024 Annual Report"), those listed under Part II, Item 1A of this Report and other filings with the SEC, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

All statements contained in this Report that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding our future results of operations and financial position, industry and business trends, business strategy, market growth, and anticipated cost savings. In some cases, these forward-looking statements can be identified by words or phrases such as "forecast", "project", "should" "may", "will", "expect", "anticipate", "aim", "estimate", "intend", "plan", "believe", "potential", "continue", "is/are likely to" or other similar expressions.

These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the risk factors set forth in our 2024 Annual Report, the risk factors set forth in this Report on Form 6-K and the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We have a history of losses, and we may be unable to achieve or sustain profitability, including due to elevated inflation and increased costs for transportation, energy, and materials;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our future business, financial condition and results of operations may be adversely affected by reduced or limited availability of oats and other raw materials and ingredients, which meet our quality standards, that our limited number of suppliers are able to sell to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•A failure to obtain necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing and development and other operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We maintain our cash and cash equivalents at financial institutions, often in balances that exceed federally insured limits. If financial institutions where we hold deposits were to fail, we could be exposed to a potential loss of deposits, and our ability to raise capital may be impacted by these events;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The primary components of all our products are manufactured in our production facilities, and damage or disruption at these facilities has in the past harmed, and may in the future harm, our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our brand or reputation may be harmed due to real or perceived quality, food safety, nutrition or sustainability issues with our products, which could have an adverse effect on our business, reputation, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Food safety and food-borne illness incidents or other safety, concerns have led to product recalls, and may materially adversely affect our business, financial condition and results of operations by exposing us to lawsuits or regulatory enforcement actions in the future, increasing our operating costs and reducing demand for our product offerings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Failure by our suppliers of raw materials or co-manufacturers to comply with food safety, environmental or other laws and regulations, or with the specifications and requirements of our products, may disrupt our supply of products and adversely affect our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We may not be able to compete successfully in our highly competitive markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Consolidation of customers, the loss of a significant customer or the decrease of sales from a significant customer, could negatively impact our sales and profitability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Sales of our oatmilk varieties contribute a significant portion of our revenue and a reduction in such sales would have an adverse effect on our business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We continue to pursue an asset-light business model, which means we will rely heavily on our co-manufacturing partners;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our strategic partnerships with our co-manufacturers may not be successful, which could adversely affect our operations and manufacturing strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Failure by our logistics providers to deliver our products on time, or at all, could result in lost sales;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We may not successfully ramp up operations at any of our facilities, or these facilities may not operate in accordance with our expectations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•If we fail to effectively expand our processing, manufacturing and production capacity through existing facilities or acceptable co-manufacturing partners as we continue to grow and scale our business to a steady operating level, our business, financial condition, results of operations and our brand reputation could be harmed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•If we fail to develop and maintain our brand, our business could suffer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Failure to develop or introduce new products or successfully improve existing products may adversely affect our ability to continue to grow;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•If we fail to cost-effectively acquire new customers and consumers or retain our existing customers and consumers, or if we fail to derive revenue from our existing customers consistent with our historical performance, our business could be materially adversely affected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Consumer preferences for our products are difficult to predict and may change, and, if we are unable to respond quickly to new trends, our business may be adversely affected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•If we fail to manage our future growth effectively, including maintenance of our workforce, our business, financial condition and results of operations could be materially adversely affected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We have recently recognized impairment charges for long-lived assets and other exit costs in connection with our production facilities, and we may need to recognize further costs in the future, which could adversely impact our business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We are subject to risks related to sustainability (including environmental, climate change and broader corporate social responsibility matters), which may materially adversely affect our business as a result of lawsuits, regulatory investigations and enforcement actions, complaints concerning our disclosures, impacts on our operations and supply chain (particularly in connection with the physical impacts of climate change), and impacts on our brand and reputation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We rely on information technology systems and any inadequacy, failure or interruption of, or cybersecurity incidents affecting, those systems may harm our reputation and ability to effectively operate our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•A cybersecurity incident or other technology disruptions could negatively impact our business and our relationships with customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our customers generally are not obligated to continue purchasing products from us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We may face difficulties as we expand our operations into countries in which we have no prior operating experience;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The international nature of our business subjects us to additional global economic and geopolitical risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The successful execution of the strategic review of the Company's Greater China operations, the outcome of the strategic review and the market reaction thereto;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our operations in China could Our operations in China could expose us to substantial business, regulatory, political, financial and economic risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our strategic reset in Asia may not be successful;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•If we fail to comply with trade compliance and economic sanctions laws and regulations of the U.S., the EU and other applicable international jurisdictions, it could materially adversely affect our reputation and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Packaging costs are volatile and may rise significantly, which may negatively impact the profitability of our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Fluctuations in our results of operations may impact, and may have a disproportionate effect on, our overall financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Litigation or legal proceedings could expose us to significant liabilities or costs and have a negative impact on our reputation or business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at similar rates, if at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Failure to retain our senior management or to attract, train and retain qualified employees may adversely affect our operations or our ability to grow successfully;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•If we cannot maintain our company culture or focus on our mission as we grow, our success and our business and competitive position may be harmed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our insurance may not provide adequate levels of coverage against claims or we may be unable to find insurance with sufficient coverage at a reasonable cost;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Disruptions in the worldwide economy may adversely affect our business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our business is affected by macroeconomic conditions, including rising inflation, interest rates and supply chain constraints;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Global conflicts, other effects of ongoing wars and conflicts, and increasing geopolitical tensions and changes to international trade policies, treaties and tariffs, including as a result of the emergence of a trade war, could negatively impact our business, results of operations, and financial condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Legal claims, government investigations or other regulatory enforcement actions could subject us to civil and criminal penalties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our operations are subject to U.S., EU, China and other laws and regulations, and there is no assurance that we will be in compliance with all regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Changes in existing laws or regulations, or the adoption of new laws or regulations may increase our costs and otherwise adversely affect our business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We are subject to stringent environmental regulation and potentially subject to environmental litigation, proceedings and investigations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We may not be able to protect, enforce or defend our intellectual property and other proprietary rights adequately, which may impact our commercial success;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We have previously identified material weaknesses in our internal control environment. If we are unable to remediate any material weakness, or if other control deficiencies are identified, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our largest shareholder has significant influence over us, including significant influence over decisions that require the approval of shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our results of operations and the market price of our ADSs have been, and may be, volatile, and you may lose all or part of your investment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Although as a foreign private issuer we are exempt from certain corporate governance standards applicable to U.S. issuers, if we cannot satisfy, or continue to satisfy, the continued listing requirements of Nasdaq it could result in a delisting of our securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We are a foreign private issuer and, as a result, we are not subject to U.S. proxy rules and are subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•You may not be able to exercise your right to vote the ordinary shares underlying your ADSs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The Company may be subject to securities litigation, which is expensive and could divert management attention;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We may not pay dividends on our ADSs in the future and, consequently, your ability to achieve a return on your investment will depend on the appreciation in the price of our ADSs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Changes in our tax rates or exposure to additional tax liabilities or assessments could affect our profitability, and audits by tax authorities could result in additional tax payments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•We have incurred substantial indebtedness that may decrease our business flexibility, access to capital, and/or increase our future borrowing costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Transactions relating to the Convertible Notes may dilute the ownership interests of holders of our ADSs or ordinary shares and may adversely impact the value of such securities; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Covenants in our debt agreements may restrict our operating activities and adversely affect our financial condition.

The forward-looking statements made in this Report relate only to events or information as of the date on which the statements are made in this Report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this Report and the documents that we reference in this Report and have filed as exhibits to this Report completely and with the understanding that our actual future results or performance may be materially different from what we expect.

------

**Overview**

We are the world's original and largest oat drink company. For over 30 years, we have exclusively focused on developing expertise around oats: a global power crop with inherent properties suited for sustainability and human health. Our commitment to oats has resulted in core technical advancements that enabled us to unlock the breadth of the dairy portfolio, including milks, ice creams, yogurts, cooking creams, spreads and on-the-go drinks. Since our founding, we have had a bold vision for a food system that is better for people and the planet. We believe that transforming the food industry is necessary to face humanity's greatest challenges across climate, environment, health and lifestyle and have not only positioned our brand to capitalize on the growing consumer interest in sustainable, plant- based foods and dairy alternatives, but we have become a driving force behind increased consumer awareness and transition from traditional dairy consumers to Oatly.

##  ***Recent Developments, Trends and Other Factors Affecting our Business*** 
*Strategic actions on Organizational Structure and Supply Chain*

We continue to execute on our strategic priorities focused on achieving profitable growth. These actions are aimed at setting clear priorities for our teams, reducing complexity to increase organizational agility, and executing a more asset-light supply chain strategy.

In executing these actions, we simplified our organizational structure. We reviewed the organizational structure to adjust the fixed cost base globally, including employee-related costs, professional services, and other related costs.

During the fourth quarter 2023, we decided to discontinue the construction of our production facilities in Peterborough, United Kingdom and Dallas-Fort Worth, Texas. During 2024, we completed substantially all of the activities relating to the exit of these two facilities. Also, in 2024, we decided to close our production facility in Singapore and discontinued the construction of our second production facility in China, which we historically referred to as "Asia III." For a further discussion on risks related to these discontinuations see Part I, Item 3.D. *"Risk Factors"* of our 2024 Annual Report.

*Strategic Review of China Business*

We have initiated a strategic review of our Greater China business. The review will consider a range of options, including a potential carve-out of the Greater China segment, with the goal of accelerating growth and maximizing the value of the business.

We continue to operate in the Greater China market, including operating our production facility, and we remain committed to our customers, consumers, and employees as we look to maximize the value of this part of the business.

There is no definitive timetable for completing the strategic review. We do not intend to provide further updates unless and until the Board of Directors have approved a specific course of action or determines that additional disclosure is appropriate or required. We caution that there can be no assurances that the process will result in any transaction or strategic change.

*Impact of the Current Macroeconomic Environment on our Results*

Our business continues to be exposed to the effects of the current global macroeconomic environment, including consumer spending, inflationary pressures, geopolitical tensions, tariffs and the current trade war, and foreign exchange impacts. We continue to maintain a global focus on the controllable aspects of the business, and will continue to actively monitor and respond accordingly to the macroeconomic environment.

For further information refer to Part I, Item 3.D. *"Risk Factors"* of our 2024 Annual Report.

***Revenue***

We generate revenue primarily from sales of our oatmilk and other oat-based products across our three segments: Europe & International, North America and Greater China. Our customers include retailers, e-commerce channels, coffee shops and other specialty providers within the foodservice industry.

Europe & International is our largest revenue-producing segment, followed by the North America and Greater China segments. Currently, our primary markets in Europe & International are the United Kingdom, Germany and Sweden. In North America, substantially all of our revenue to date can be attributed to the United States, and in Greater China, the majority of our revenue is generated in China. The channel and product

------

mix vary by country, where our more mature markets, such as Sweden and Finland, have a broader product portfolio available to customers and consumers. For the six months ended June 30, 2025, on a consolidated level, oatmilk accounted for 91% of our revenue (2024: 89%).

We routinely offer sales discounts and promotions through various programs to customers. These programs include rebates, temporary on-shelf price reductions, retailer advertisements, product coupons and other trade activities. The expense associated with these discounts and promotions is estimated and recorded as a reduction in total gross revenue in order to arrive at reported revenue. These promotional activities impact our revenue and changes in such activities could impact period-over-period results.

The following factors and trends in our business have driven revenue growth over prior periods and are expected to be key drivers of our revenue growth going forward:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Continue to expand household penetration to reach new consumers and increase the repeat purchase rates of existing consumers by continuing to invest in advertising and marketing to increase awareness of our brand and products.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Expand our presence across channels:

oGrow within food retail channels by increasing our distribution points with existing and new customers, capturing greater shelf space and continuing to drive velocity increases.

oExpand footprint across the foodservice channel, including independent coffee shops, branded foodservice restaurant chains, and other foodservice customers such as universities and offices.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Scale e-commerce capabilities by strategically partnering with leading third-party platforms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Extend product offering through new product development within existing and new product categories to capture the market-specific consumer needs in each of the regions in which we operate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Enter new international markets through our proven foodservice-led strategy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Optimize global production capacity to meet consumer demand.

***Cost of goods sold***

Cost of goods sold consists primarily of the cost of oats and other raw materials, product packaging, co-manufacturing fees, direct labor and associated overhead costs and property, plant and equipment depreciation. Our cost of goods sold also includes warehousing and transportation of inventory. We expect our cost of goods sold to increase in absolute dollars to support our growth. However, we expect that, over time, cost of goods sold will decrease as a percentage of revenue, as a result of the scaling of our business and optimizing our production footprint.

***Gross profit and margin***

Gross profit consists of our revenue less costs of goods sold. We have scaled our production capacity significantly over the past couple of years. Our gross profit and gross margin have benefited, and we expect will continue to benefit, from the reduction in cost of goods sold driven by an increased focus on our asset-light supply chain strategy, improvements in our manufacturing operational performance, leveraging the cost of our fixed production costs, as well as a higher focus on procurement efficiencies through scale of purchasing and diversification of suppliers. Additionally, our gross margin has benefited, and we expect will continue to benefit, from an improved mix of products sold driven by the reduction or elimination of low-margin products and the growth or addition of higher-margin products.

***Operating expenses***

*Research and development expenses* consist primarily of personnel-related expenses for our research and development staff, including salaries, benefits and bonuses, but also third-party consultancy fees and expenses incurred related to product trial runs. Our research and development efforts are focused on enhancements to our existing product formulations and production processes in addition to the development of new products.

*Selling, general and administrative expenses* include primarily personnel-related expenses for our sales, general and administrative staff, brand awareness and advertising costs, costs associated with consumer promotions, product samples and sales aids. These also include customer distribution costs, i.e., outbound shipping and handling costs for finished goods, and other functional related selling and marketing expenses, depreciation and amortization expense on non-manufacturing assets and other miscellaneous operating items. Selling, general and administrative expenses also include auditor fees and other third-party consultancy fees, expenses related to management, finance and accounting, information technology, human resources and other office functions.

------

*Other operating income and (expenses), net,* consists primarily of impacts related to strategic review of the Greater China segment, closure of production facility, discontinued construction of certain production facilities and net foreign exchange gains (losses) on operating related activities.

***Other*** 

*Finance income and (expenses), net,* primarily consists of fair value changes on Convertible Notes, transaction costs relating to amendments in our financing arrangements, interest expenses related to Convertible Notes and loans from credit institutions, interest expenses on lease liabilities, interest income and foreign exchange gains and losses attributable to our external and internal financing arrangements.

*Income tax expense* represents both current and deferred income tax expenses. Current tax expenses primarily represent income taxes based on income in multiple foreign jurisdictions.

##  ***Results of Operations*** 
The following table sets forth the interim condensed consolidated statements of operations in U.S. dollars and as a percentage of revenue for the periods presented.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
|  | **(in thousands)** | **% of<br>revenue** | **(in thousands)** | **% of<br>revenue** | **(in thousands $)** | **% of<br>revenue** | **(in thousands $)** | **% of<br>revenue** |
| Revenue | 208354 | 100.0% | 202195 | 100.0% | 405884 | 100.0% | 401350 | 100.0% |
| Cost of goods sold | (140729) | (67.5)% | (143239) | (70.8)% | (275929) | (68.0)% | (288496) | (71.9)% |
| **Gross profit** | **67625** | **32.5%** | **58956** | **29.2%** | **129955** | **32.0%** | **112854** | **28.1%** |
| Research and development expenses | (4605) | (2.2)% | (10898) | (5.4)% | (8996) | (2.2)% | (15540) | (3.9)% |
| Selling, general and administrative expenses | (84111) | (40.4)% | (84261) | (41.7)% | (161609) | (39.8)% | (163003) | (40.6)% |
| Other operating income and (expenses), net | (1025) | (0.5)% | (2876) | (1.4)% | (57) | (0.0)% | (1803) | (0.4)% |
| **Operating loss** | **(22116)** | **(10.6)%** | **(39079)** | **(19.3)%** | **(40707)** | **(10.0)%** | **(67492)** | **(16.8)%** |
| Finance income and (expenses), net | (31916) | (15.3)% | 10389 | 5.1% | (22505) | (5.5)% | (6988) | (1.7)% |
| **Loss before tax** | **(54032)** | **(25.9)%** | **(28690)** | **(14.2)%** | **(63212)** | **(15.6)%** | **(74480)** | **(18.6)%** |
| Income tax expense | (1914) | (0.9)% | (1751) | (0.9)% | (5265) | (1.3)% | (1805) | (0.4)% |
| **Loss for the period** | **(55946)** | **(26.9)%** | **(30441)** | **(15.1)%** | **(68477)** | **(16.9)%** | **(76285)** | **(19.0)%** |
| Attributable to: |  |  |  |  |  |  |  |  |
| Shareholders of the parent | (55911) | (26.8)% | (30384) | (15.0)% | (68341) | (16.8)% | (76183) | (19.0)% |
| Non-controlling interests | (35) | (0.0)% | (57) | (0.0)% | (136) | (0.0)% | (102) | (0.0)% |

---

***For the three and six months ended June 30, 2025***

*Revenue*

Revenue increased $6.2 million, or 3.0%, to $208.4 million for the three months ended June 30, 2025, net of sales discounts, rebates and trade promotions, compared to $202.2 million for the three months ended June 30, 2024. Excluding a foreign currency exchange tailwind of $6.6 million, revenue for the second quarter was $201.7 million, or a decrease of 0.2% compared to the prior year period (refer to Non-IFRS Financial Measures section below for tables reconciling revenue as reported to revenue on a constant currency basis by segment). The decrease in constant currency revenue was primarily driven by decline in North America and Greater China, partially offset by strong growth in Europe and International. Sold volume for the three months ended June 30, 2025 amounted to 140.4 million liters compared to 136.6 million liters for the three months ended June 30, 2024. Produced finished goods volume for the second quarter of 2025 amounted to 142.8 million liters compared to 142.0 million liters for the same period last year.

We continued to experience revenue growth in the retail channel of 12.2% for the three months ended June 30, 2025 compared to the prior year period. In the three months ended June 30, 2025 and 2024, the retail channel accounted for 65.8% and 60.5% of our revenue, respectively,

------

the foodservice channel accounted for 31.8% and 35.6% of our revenue, respectively, and the other channel, comprised primarily of e-commerce sales, accounted for 2.4% and 3.9% of our revenue, respectively.

Europe & International, North America and Greater China accounted for 56.7%, 30.3% and 13.0% of our total revenue in the three months ended June 30, 2025, respectively, as compared to 52.2%, 33.5% and 14.3% of our total revenue in the three months ended June 30, 2024, respectively.

Revenue increased $4.5 million, or 1.1%, to $405.9 million for the six months ended June 30, 2025, net of sales discounts, rebates and trade promotions, compared to $401.4 million for the six months ended June 30, 2024. Excluding a foreign currency exchange tailwind of $3.8 million, revenue was $402.1 million, or an increase of 0.2% compared to the prior year period (refer to Non-IFRS Financial Measures section below for tables reconciling revenue as reported to revenue on a constant currency basis by segment). The revenue growth was primarily driven by volume growth across the Europe & International and Greater China segments, partially offset by volume decline in North America as well as price/mix declines in the Europe & International and Greater China segments. Sold volume for the six months ended June 30, 2025 amounted to 284.9 million liters compared to 268.9 million liters for the six months ended June 30, 2024. Produced finished goods volume for the six months ended June 30, 2025 amounted to 285.8 million liters compared to 283.0 million liters for the same period last year.

We continued to experience revenue growth in the retail channel of 4.5% for the six months ended June 30, 2025 compared to the prior year period. In the six months ended June 30, 2025 and 2024, the retail channel accounted for 64.7% and 62.7% of our revenue, respectively, the foodservice channel accounted for 33.0% and 33.8% of our revenue, respectively, and the other channel, comprised primarily of e-commerce sales, accounted for 2.3% and 3.5% of our revenue, respectively.

Europe & International, North America and Greater China accounted for 55.7%, 30.3% and 14.0% of our total revenue in the six months ended June 30, 2025, respectively, as compared to 53.8%, 33.6% and 12.6% of our total revenue in the six months ended June 30, 2024, respectively.

The increase in sold volume growth in Europe & International was driven by continued expansion in core markets, as well as incremental contributions from new markets. The revenue growth was assisted by foreign exchange tailwinds but partially offset by a price/mix decline. In North America, our sold volume and revenue decreased primarily due to lower volumes in the foodservice channel. Finally, Greater China revenue growth was primarily driven by sales to a new foodservice customer.

As a result of the strategic actions and restructuring activities we have undertaken to simplify our organizational structure, our number of employees has decreased by 39 employees, to 1,426 employees as of June 30, 2025 from 1,465 employees as of June 30, 2024. The average number of full-time consultants increased by 13 consultants to 88 consultants for the six months ended June 30, 2025 from 75 consultants for the six months ended June 30, 2024.

*Cost of goods sold*

Cost of goods sold decreased by $2.5 million, or 1.8%, to $140.7 million for the three months ended June 30, 2025, from $143.2 million for the three months ended June 30, 2024.

Cost of goods sold decreased by $12.6 million, or 4.4%, to $275.9 million for the six months ended June 30, 2025, from $288.5 million for the six months ended June 30, 2024.

The decrease for the three and six months ended June 30, 2025 was primarily driven by an increase in supply chain efficiencies, especially in the Europe & International segment.

*Gross profit and margin*

Gross profit increased by $8.6 million, or 14.7%, to $67.6 million for the three months ended June 30, 2025, from $59.0 million for the three months ended June 30, 2024. Gross profit margin increased by 3.3 percentage points, to 32.5% for the three months ended June 30, 2025, from 29.2% for the three months ended June 30, 2024.

Gross profit increased by $17.1 million, or 15.2%, to $130.0 million for the six months ended June 30, 2025, from $112.9 million for the six months ended June 30, 2024. Gross profit margin increased by 3.9 percentage points, to 32.0% for the six months ended June 30, 2025, from 28.1% for the six months ended June 30, 2024.

The increase for the three and six months ended June 30, 2025 in gross profit margin was primarily driven by improvements in supply chain efficiency, especially in the Europe & International segment.

------

*Research and development expenses*

Research and development expenses decreased by $6.3 million, or 57.7%, to $4.6 million for the three months ended June 30, 2025, from $10.9 million for the three months ended June 30, 2024 and decreased as a share of revenues 2.2% and 5.4%, respectively.

Research and development expenses decreased by $6.5 million, or 42.1%, to $9.0 million for the six months ended June 30, 2025, from $15.5 million for the six months ended June 30, 2024 and decreased as a share of revenues 2.2% and 3.9%, respectively.

The decrease for the three and six months ended June 30, 2025 was mainly driven by expenses in the prior year period related to a new product launch issue in the North America segment.

*Selling, general and administrative expenses*

Selling, general and administrative expenses decreased by $0.2 million, or 0.2%, to $84.1 million for the three months ended June 30, 2025 compared to $84.3 million for the three months ended June 30, 2024 and decreased as a share of revenue to 40.4% from 41.7%, respectively. The decrease was primarily due to the continued cost savings initiatives. Customer distribution expense increased as a share of revenue to 6.3% from 6.0%.

Selling, general and administrative expenses decreased by $1.4 million, or 0.9%, to $161.6 million for the six months ended June 30, 2025 compared to $163.0 million for the six months ended June 30, 2024 and decreased as a share of revenue to 39.8% from 40.6%, respectively. The decrease was primarily due to the various cost restructuring activities implemented since early 2023, which were partially offset by foreign exchange headwinds. Customer distribution expense increased as a share of revenue to 6.5% from 6.2%.

*Other operating income and (expenses), net*

Other operating income and (expenses), net for the three months ended June 30, 2025 was an expense of $1.0 million comprised primarily of $1.4 million in costs for our strategic review of our Greater China segment. Other operating income and (expenses), net for the three months ended June 30, 2024 was an expense of $2.9 million comprised primarily of non-cash impairment charges related to the Group's discontinued construction of its production facility in Peterborough, UK.

Other operating income and (expenses), net for the six months ended June 30, 2025 was an expense of $0.1 million comprised primarily of $1.4 million in costs for our strategic of our Greater China segment, offset by mainly $0.8 in reversal of other exit costs related to the closure of the production facility in Singapore. Other operating income and (expenses), net for the six months ended June 30, 2024 was an expense of $1.8 million comprised primarily of $2.9 million in non-cash impairment charges related to the Group's discontinued construction of its production facility in Peterborough, partially offset by $0.9 million in reversal of previously recognized non-cash impairment charges related to the Group's discontinued construction of its production facility in Dallas-Fort Worth, Texas.

*Finance income and (expenses), net*

Finance income and (expenses), net for the three months ended June 30, 2025 was an expense of $31.9 million comprised primarily of net interest expenses of $14.9 million, fair value losses on Convertible Notes of $8.6 million, and net foreign exchange loss of $7.8 million. The finance income and (expenses), net for the three months ended June 30, 2024 was an income of $10.4 million comprised primarily of fair value gains on Convertible Notes of $23.9 million, offset by net interest expenses of $13.0 million.

Finance income and (expenses), net for the six months ended June 30, 2025 was an expense of $22.5 million comprised primarily of net interest expenses of $28.5 million and net foreign exchange loss of $5.6 million, offset by fair value gains on Convertible Notes of $13.5 million. The finance income and (expenses), net for the six months ended June 30, 2024 was an expense of $7.0 million comprised primarily of net interest expenses of $25.3 million and other financial expenses of $5.7 million, offset by fair value gains on Convertible Notes of $23.0 million.

*Income tax expense*

Income tax expense increased to $1.9 million for the three months ended June 30, 2025 compared to $1.8 million for the three months ended June 30, 2024. The effective tax rates for the three months ended June 30, 2025 was 3.5%. The main drivers of the effective tax rate relate to non-recognition of deferred tax assets on tax losses and tax effect relating to foreign exchange effects recognized in other comprehensive income. The effective tax rate for the three months ended June 30, 2024 was 6.1%, with non-recognition of deferred tax assets on tax losses being the main driver of the effective tax rate.

Income tax expense increased to $5.3 million for the six months ended June 30, 2025 compared to $1.8 million for the six months ended June 30, 2024. The effective tax rates for the six months ended June 30, 2025 was 8.3%. The main drivers of the effective tax rate relate to

------

non-recognition of deferred tax assets on tax losses and tax effect relating to foreign exchange effects recognized in other comprehensive income. The effective tax rate for the six months ended June 30, 2024 was 2.4%, with non-recognition of deferred tax assets on tax losses being the main driver of the effective tax rate.

##  ***Liquidity and Capital Resources*** 
Since our inception, we have financed our operations primarily through cash generated by the issuance of equity and Convertible Notes, and from borrowings under our credit facilities. Our primary requirements for liquidity and capital are to finance working capital, make capital expenditures, invest in our organizational capabilities to support profitable growth and for general corporate purposes. We are using this combination of financing to fund our business. We expect our capital expenditures for 2025 to be approximately $20 million, related primarily to investments in our production facilities. The amount and allocation of our future capital expenditures depend on several factors, and our strategic investment priorities may change. Our recent decisions to discontinue construction at the production facility in China (Asia III), and close the production facility in Singapore, have impacted our projected capital expenditures. We believe that our sources of liquidity and capital will be sufficient to meet our existing business needs for at least the next 12 months. See the risk factor entitled *"A failure to obtain necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing and development and other operations"* under Part I, Item 3.D. *"Risk Factors"* of our 2024 Annual Report.

Our primary sources of liquidity are cash and cash equivalents on hand and availability under our credit facilities. As of June 30, 2025, we had cash and cash equivalents of $67.9 million. Our cash and cash equivalents consist of cash in bank accounts.

In addition to the above, we had access to $221.0 million in undrawn bank facilities as of June 30, 2025.

***Sustainable Revolving Credit Facility and Term Loan B Credit Facility*** 

On April 18, 2023, the Company's existing Sustainable Revolving Credit Facility Agreement (the "SRCF Agreement") was amended and restated whereby, among other things, (i) the term of the SRCF Agreement was reset to three years and six months, with a one year uncommitted extension option, (ii) the lender group under the SRCF Agreement was reduced to JP Morgan SE, BNP Paribas SA, Bankfilial Sverige, Coöperatieve Rabobank U.A. and Nordea Bank Abp, filial i Sverige and the commitments under the SRCF Agreement were reduced to SEK 2,100 million (equivalent of $192.1 million), with an uncommitted incremental revolving facility option of up to SEK 500 million (equivalent of $45.7 million), (iii) the initial margin was reset at 4.00% p.a., (iv) the tangible solvency ratio, minimum EBITDA, minimum liquidity and total net leverage ratio financial covenants were reset, (v) the existing negative covenants were amended to further align with those included in the TLB Credit Agreement (as defined below), including in relation to incurrence of indebtedness, and (vi) the debt under the SRCF Agreement ranks pari passu with, and shares in the same security and guarantees from the Group as, the EIF Facility (as defined below) and the TLB Credit Agreement by way of the Intercreditor Agreement (as defined below).

On April 18, 2023, we entered into a Term Loan B Credit Agreement (the "TLB Credit Agreement") with, amongst others, Silver Point Finance LLC as Syndication Agent and Lead Lender, J.P. Morgan SE, as Administrative Agent and Wilmington Trust (London) Limited as Security Agent, including a term loan facility of $130 million. The term of the TLB Credit Agreement is five years from the funding date of the term loan facility, and the term loan facility is subject to 1% amortization per annum paid in quarterly installments. Borrowings carry an interest rate of Term SOFR (with a floor of 2.50%) plus 7.5% or Base Rate (with floor of 3.50%) plus 6.5%. The TLB Credit Agreement contains maintenance financial covenants such as minimum EBITDA, total net leverage ratio and liquidity requirements. The TLB Credit Agreement also contains certain negative covenants, including but not limited to restrictions on indebtedness, limitations on liens, fundamental changes covenant, asset sales covenant, and restricted payments covenant. The debt under the TLB Credit Agreement ranks pari passu with, and shares in the same security and guarantees from the Group as, the EIF Facility (as defined below) and the SRCF Agreement by way of the Intercreditor Agreement. As of June 30, 2025, we had $130.4 million, including accrued interest, outstanding under the TLB Credit Agreement.

On April 18, 2023, the Company, Oatly AB, Oatly Inc. and other parties entered into an intercreditor agreement (the "Intercreditor Agreement") with, amongst others J.P. Morgan SE, as Senior Secured Term Facilities Agent, Wilmington Trust (London) Limited as Senior Secured Revolving Facilities Agent, Wilmington Trust (London) Limited as Common Security Agent and U.S. Bank Trust Company, National Association as trustee in respect of certain of the Convertible Notes (as defined below). The Intercreditor Agreement includes customary ranking, enforcement and turnover provisions intended to govern the relationship between the creditor groups.

In May 2023, (i) the SRCF Agreement was amended pursuant to an amendment letter to, among other things, ensure that the Convertible Notes constitute "PIPE Financing" under and as defined in the SRCF Agreement and (ii) the TLB Credit Agreement was amended pursuant to an amendment agreement to, among other things, ensure that the Convertible Notes constitute "Convertible Bonds" under and as defined in the TLB Credit Agreement.

On February 14, 2024, the SRCF Agreement and the TLB Credit Agreement were amended and restated to, among other things, (i) reset the financial covenant levels applying to the minimum EBITDA (including separate testing of the Group's Europe & International EBITDA, the

------

definition of which has subsequently been corrected by way of subsequent amendment), minimum liquidity and total net leverage ratio financial covenants and, in relation to the SRCF Agreement, the tangible solvency ratio financial covenant, (ii) revise certain financial definitions to permit additional adjustments for the purpose of the calculation of the financial covenants and (iii) provide certain flexibility for disposals of assets relating to our production facilities in Dallas Fort Worth, Texas, United States of America and Peterborough, United Kingdom. In addition, the existing draw-stop level for the SRCF Agreement, which requires that a certain amount of such facility remains undrawn for as long as the last twelve months' ("LTM") consolidated EBITDA of the Group is negative, has been increased from $50 million to $100 million, and the original 24 months' non-call/make-whole period applying under the TLB Credit Agreement has been reset to apply for the 18 months following the amendment effective date (for the avoidance of doubt, the subsequent 12 months' prepayment fee period still applies after the end of such 18-month period).

Under the amended SRCF Agreement and TLB Credit Agreement, the total net leverage ratio financial covenant, tested in respect of the LTM period ending on each quarter date, will start to apply in respect of the LTM period ending on December 31, 2026, and the applicable financial covenant level will be 4.50:1, stepping down to 3.50:1 for each LTM period ending in 2027 and to 3.00:1 for each LTM period in 2028. The reset quarterly tangible solvency ratio financial covenant level applying under the amended SRCF Agreement is 30%.

On February 11, 2025, the SRCF Agreement and TLB Credit Agreement were amended and restated to, among other things, (i) reset certain financial covenant levels applying to the minimum liquidity financial covenant, (ii) revise certain financial definitions to permit additional adjustments for the purpose of the calculation of certain financial covenants, including in relation to certain costs relating to the discontinuance of certain of the Group's manufacturing facilities and (iii) provide certain flexibility for disposals of assets relating to the relevant manufacturing facilities.

The amended SRCF Agreement and TLB Credit Agreement impose limitations on drawdowns under the SRCF Agreement (other than under ancillary facilities, such as overdraft facilities and bank guarantees, which are exempted from these limitations) based on the last four quarters' consolidated EBITDA of the Group, where, if last four quarters' consolidated EBITDA of the Group is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) less than $0, $0 may be drawn; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) equal to or greater than $75 million, the full amount of the existing facility may be drawn,

with interim steps in between, and increases requiring improved performance for two consecutive four quarter periods and reductions requiring decreased performance for one four quarter period.

***Convertible Notes*** 

On March 23, 2023 and April 18, 2023, we issued $300 million aggregate principal amount of 9.25% Convertible Senior PIK Notes due 2028 (the notes issued on March 23, 2023, the "U.S. Notes" and the notes issued on April 18, 2023, the "Swedish Notes" and, together with the U.S. Notes, the "Original Convertible Notes" and the Original Convertible Notes, together with the HH Notes (as defined below), the "Convertible Notes"). The U.S. Notes and the Swedish Notes have substantially identical economic terms.

Certain of our existing shareholders, Nativus Company Limited, Verlinvest S.A ("Verlinvest") and Blackstone Funds, purchased $200.1 million aggregate principal amount of the Swedish Notes and other institutional investors purchased $99.9 million aggregate principal amount of the U.S. Notes. The investors paid an aggregate purchase price of $291 million, reflecting an original issue discount of 3%.

The Convertible Notes bear interest at a rate of 9.25% per annum, payable semi-annually in arrears in cash or in payment-in-kind, at our option, on April 15 and October 15 of each year, beginning on October 15, 2023. The Convertible Notes will mature on September 14, 2028, unless earlier converted by the holders or required to be converted, repurchased or redeemed by us. The Original Convertible Notes were convertible at the option of each holder at an initial conversion price of $2.41 per ordinary share or per ADS, subject to customary anti-dilution adjustments and conversion rate resets. On March 23, 2024, the conversion price of the Original Convertible Notes was reset to $1.81 in accordance with the terms thereof. On February 18, 2025, we completed a ratio change whereby the ratio of our ADSs to ordinary shares was changed from one ADS representing one ordinary share to one ADS representing twenty ordinary shares (the "ADS Ratio Change"). As a result of the ADS Ratio Change, the conversion price of the U.S. Notes was proportionately adjusted from $1.81 to $36.20. The conversion price of the U.S. Notes was reset again on March 23, 2025, to $27.20.

Because the Swedish Notes are convertible into ordinary shares rather than ADSs, the ADS Ratio Change did not affect the conversion price and conversion rate of the Swedish Notes. In order to ensure that the holders of the Swedish Notes remain in the same economic position as before the ADS Ratio Change and to preserve economic equivalency of the Swedish Notes with the U.S. Notes and the HH Notes, we, in accordance with the Swedish Terms, will interpret the definition of "Daily VWAP" therein to assume the trading price of 1/20 of an ADS. The conversion price of the Swedish Notes was reset again on March 23, 2025, to $1.36.

We may require conversion of the Convertible Notes if the last reported sale price of our ADSs equals or exceeds 200% of the applicable conversion price (in the case of the Swedish Notes, the definition of "Last Reported Sale Price" is interpreted to equal 1/20 of an ADS) on any

------

45 trading days during any 90 consecutive day period beginning on or after the third anniversary of the issuance of the U.S. Notes (with respect to the U.S. Notes and the HH Notes) and the Swedish Notes (with respect to the Swedish Notes).

On April 18, 2023, we, Oatly AB, Oatly Inc. and other parties entered into the Intercreditor Agreement which includes customary ranking, enforcement and turnover provisions intended to govern the relationship between the creditor groups and which affect the Convertible Notes.

On May 9, 2023, we entered into an agreement with an affiliate of Hillhouse Investment Management Ltd. ("Hillhouse") to sell an additional $35 million in Convertible Senior PIK Notes due 2028 (the "HH Notes"), resulting in approximately $34 million in financing after reflecting an original issue discount of 3%. The economic terms of the HH Notes are substantially identical to the economic terms of the U.S. Notes, except (i) that the HH Notes were convertible at Hillhouse's option at an initial conversion price of $2.52 per ADS, representing an approximate 17% premium to the last reported sale price of our ADSs on the Nasdaq Global Market on May 8, 2023, and (ii) with respect to the specified prices in connection with the conversion rate resets of the HH Notes. On March 23, 2024, the conversion price of the HH Notes was reset to $1.89 in accordance with the terms thereof. As a result of the ADS Ratio Change, the conversion price of the HH Notes was proportionately adjusted from $1.89 to $37.80. The conversion price of the HH Notes was reset again on March 23, 2025, to $28.20. In addition, on May 9, 2023, one of the existing holders of Swedish Notes and an affiliate of one of our shareholders, Verlinvest, agreed to sell and Hillhouse agreed to purchase from Verlinvest $15 million aggregate principal amount of Swedish Notes (the "Resale Notes"). The purchase and sale of the HH Notes and the Resale Notes closed on May 31, 2023. The HH Notes are also subject to the Intercreditor Agreement.

The terms of the Convertible Notes contain covenants limiting our ability to incur additional debt other than certain debt permitted under the TLB Credit Agreement, issue preferred stock, and incur convertible debt or subordinated debt, in each case without the consent of the holders of a majority of the Convertible Notes (as determined pursuant to the applicable terms of the Convertible Notes).

 ***Other Credit Facilities***

In October 2019, we entered into a European Investment Fund guaranteed three-year term loan facility of €7.5 million (equivalent of $8.0 million) with Svensk Exportkredit (the "EIF Facility"). The EIF Facility bears interest at EURIBOR + 2.75%. On October 6, 2022, the termination date of the EIF Facility was extended to October 11, 2025, and the amortization schedule thereunder revised, with amortizations in an amount of €0.3 million to be made on a quarterly basis effective January 11, 2023. The loan facility and interest margin remained unchanged.

On February 14, 2024, the EIF Facility was amended and restated to, where and to the extent applicable, implement equivalent amendments as those made to the SRCF Agreement on February 14, 2024.

On February 11, 2025, the EIF Facility was amended and restated to, where and to the extent applicable, implement equivalent amendments as those made to the SRCF Agreement on February 11, 2025.

On March 19, 2025, Oatly Shanghai Co., Ltd. entered into a new RMB 30 million (equivalent of $4.2 million) working capital credit facility with China Merchants Bank Co., Ltd. Shanghai Branch (the "CMB Credit Facility"). Individual utilizations under the CMB Credit Facility are subject to the lender's approval. The CMB Credit Facility is available for one year, is unsecured, and includes creditor protection in the form of, among other things, representations, covenants (including negative pledge, restrictions on borrowings, investments and dispositions by Oatly Shanghai Co., Ltd., distributions by Oatly Shanghai Co., Ltd. and entry into transactions with its affiliates) and events of default. As of June 30, 2025, the Group had no utilized loan amounts under the amended CMB Credit Facility.

As of June 30, 2025, we had €0.6 million (equivalent of $0.7 million) outstanding under the EIF Facility, including accrued interest.

##  ***Cash Flows*** 
The following table presents the summary consolidated cash flow information for the periods presented.

---

| | | |
|:---|:---|:---|
| **(Unaudited)** | **Six months ended June 30,** | **Six months ended June 30,** |
| **(in thousands of U.S. dollars)** | **2025** | **2024** |
| Net cash flows used in operating activities | (15005) | (86013) |
| Net cash flows (used in)/from investing activities | (10220) | 858 |
| Cash flows used in financing activities | (8151) | (20213) |

---

***Net cash used in operating activities***

Net cash flows used in operating activities decreased by $71.0 million, to $15.0 million for the six months ended June 30, 2025 from $86.0 million for the six months ended June 30, 2024, which was driven by improved operating results and improvements in net working capital.

------

***Net cash (used in)/from investing activities***

Net cash flows (used in)/from investing activities decreased by $11.1 million, to an outflow of $10.2 million for the six months ended June 30, 2025 compared to an inflow of $0.9 million for the six months ended June 30, 2024. During the six months ended June 30, 2025 our investments in property, plant and equipment amounted to $9.8 million. For the six months ended June 30, 2024 our investments in property plant and equipment amounted to $19.6 million which was offset by proceeds from sale of property, plant and equipment of $20.4 million related to sold assets due to the discontinued construction of our new production facilities in Peterborough, UK and Dallas-Fort Worth, Texas.

***Net cash used in financing activities***

Net cash flows used in financing activities decreased by $12.1 million, to an outflow of $8.2 million for the six months ended June 30, 2025 from an outflow of $20.2 million for the six months ended June 30, 2024, which was primarily driven by lower repayment of lease liabilities in 2025.

##  ***Contractual Obligations and Commitments*** 
For information regarding our contractual commitments and contingencies, see Note 25 *Commitments and Contingencies* to our interim condensed consolidated financial statements, which are included elsewhere in this Report.

##  ***Non-IFRS Financial Measures*** 
We use EBITDA, Adjusted EBITDA, Constant Currency Revenue as non-IFRS financial measures in assessing our operating performance and Free Cash Flow as a non-IFRS liquidity measure, and each in our financial communications.

"EBITDA" is defined as loss for the period adjusted to exclude, when applicable, income tax expense, finance expenses, finance income and depreciation and amortization expense.

"Adjusted EBITDA" is defined as loss for the period adjusted to exclude, when applicable, income tax expense, finance expenses, finance income, depreciation and amortization expense, share-based compensation expense, restructuring costs, costs related to the strategic review of the Greater China business, impacts related to the closure of production facility, discontinued construction of production facilities, expenses related to a new product launch issue and non-controlling interests.

Adjusted EBITDA should not be considered as an alternative to loss for the period or any other measure of financial performance calculated and presented in accordance with IFRS. There are a number of limitations related to the use of Adjusted EBITDA rather than loss for the period, which is the most directly comparable IFRS measure. Some of these limitations are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA excludes depreciation and amortization expense and, although these are non-cash expenses, the assets being depreciated may have to be replaced in the future increasing our cash requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect interest expense, or the cash required to service our debt, which reduces cash available to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect income tax payments that reduce cash available to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect recurring share-based compensation expense and, therefore, does not include all of our compensation costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect restructuring costs that reduce cash available to us in future periods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect costs related to the strategic review of the Greater China business that reduce cash available to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA excludes impacts related to the closure of production facility, although some of these may reduce cash available to us in future periods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA excludes impacts related to discontinued construction of production facilities, although some of these may reduce cash available to us in future periods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect expenses related to a new product launch issue that reduce cash available to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure.

------

Adjusted EBITDA should not be considered in isolation or as a substitute for financial information provided in accordance with IFRS. Below we have provided a reconciliation of EBITDA and Adjusted EBITDA to loss for the period, the most directly comparable financial measure calculated and presented in accordance with IFRS, for the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| **(in thousands of U.S. dollars)** | **2025** | **2024** | **2025** | **2024** |
| Loss for the period | (55946) | (30441) | (68477) | (76285) |
| Income tax expense | 1914 | 1751 | 5265 | 1805 |
| Finance (income) and expenses, net | 31916 | (10389) | 22505 | 6988 |
| Depreciation and amortization expense | 12294 | 12308 | 23475 | 25321 |
| **EBITDA** | **(9822)** | **(26771)** | **(17232)** | **(42171)** |
| Share-based compensation expense | 3453 | 4179 | 7045 | 6794 |
| Restructuring costs<sup>(1)</sup> | 1393 | 3214 | 2225 | 3635 |
| Strategic review of Greater China business<sup>(2)</sup> | 1378 |  | 1378 |  |
| Closure of production facility<sup>(3)</sup> |  |  | (846) |  |
| Discontinued construction of production facilities<sup>(4)</sup> |  | 2646 |  | 1762 |
| New product launch issue<sup>(5)</sup> |  | 5677 |  | 5677 |
| Non-controlling interests | 35 | 58 | 136 | 102 |
| **Adjusted EBITDA** | **(3563)** | **(10997)** | **(7294)** | **(24201)** |

---

(1)Relates primarily to severance costs as the Group adjusts its organizational structure.

(2)Relates to costs for the strategic review of the Greater China segment.

(3)Relates to reversal of previously recognized exit costs related to closure of the Group's production facility in Singapore.

(4)Relates primarily to non-cash impairments related to discontinued construction of the Group's production facility in Peterborough, UK, and reversal of previously recognized non-cash impairments related to discontinued construction of the Group's production facility in Dallas-Fort Worth, Texas.

(5)Expenses related to a new product launch issue.

"Constant Currency Revenue" is calculated by translating the current year reported revenue amounts into comparable amounts using the prior year reporting period's average foreign exchange rates which have been provided by a third party. Constant Currency Revenue is a non-IFRS measure and is not a substitute for IFRS measures in assessing our overall financial performance.

Constant currency revenue is used to provide a framework in assessing how our business and geographic segments performed excluding the effects of foreign currency exchange rate fluctuations and we believe this information is useful to investors to facilitate comparisons and better identify trends in our business.

The table below reconciles revenue as reported to revenue on a constant currency basis by segment for the three and six months ended June 30, 2025

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three months ended June 30,** | **Three months ended June 30,** | **$ Change** | **$ Change** | **$ Change** | **% Change** | **% Change** |  |  |
| **<br>(in thousands of U.S. dollars)** | **2025** | **2024** | **As reported** | **Foreign exchange impact** | **In constant currency** | **As reported** | **In constant currency** | **Volume** | **Constant currency price/mix** |
| Europe & International | 118193 | 105541 | 118193 | 6593 | 111600 | 12.0% | 5.7% | 9.4% | -3.7% |
| North America | 63185 | 67819 | 63185 |  | 63185 | -6.8% | -6.8% | -7.5% | 0.7% |
| Greater China | 26976 | 28835 | 26976 | 49 | 26927 | -6.4% | -6.6% | -1.2% | -5.4% |
| **Total revenue** | **208354** | **202195** | **208354** | **6642** | **201712** | **3.0%** | **-0.2%** | **2.8%** | **-3.0%** |
| **(Unaudited)** | **Six months ended June 30,** | **Six months ended June 30,** | **$ Change** | **$ Change** | **$ Change** | **% Change** | **% Change** |  |  |
| **<br>(in thousands of U.S. dollars)** | **2025** | **2024** | **As reported** | **Foreign exchange impact** | **In constant currency** | **As reported** | **In constant currency** | **Volume** | **Constant currency price/mix** |
| Europe & International | 225858 | 215948 | 225858 | 3991 | 221867 | 4.6% | 2.7% | 6.6% | -3.9% |
| North America | 123071 | 134786 | 123071 |  | 123071 | -8.7% | -8.7% | -9.2% | 0.5% |
| Greater China | 56955 | 50616 | 56955 | (240) | 57195 | 12.5% | 13.0% | 32.5% | -19.5% |
| **Total revenue** | **405884** | **401350** | **405884** | **3751** | **402133** | **1.1%** | **0.2%** | **6.0%** | **-5.8%** |

---

------

"Free Cash Flow" is defined as net cash flows used in operating activities less capital expenditures. We believe Free Cash Flow is a useful supplemental financial measure for us and investors in assessing our ability to pursue business opportunities and investments. Free Cash Flow is not a measure of our liquidity under IFRS and should not be considered as an alternative to net cash flows used in operating activities.

Free Cash Flow is a non-IFRS measure and is not a substitute for IFRS measures in assessing our overall financial liquidity. Because Free Cash Flow is not a measurement determined in accordance with IFRS, and is susceptible to varying calculations, it may not be comparable to other similarly titled measures presented by other companies. Free Cash Flow should not be considered in isolation, or as a substitute for an analysis of our results as reported on our interim condensed consolidated financial statements appearing elsewhere in this document. Below we have provided a reconciliation of Free Cash Flow to net cash flows used in operating activities for the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
| **(in thousands of U.S. dollars)** | **2025** | **2024** | **2025** | **2024** |
| Net cash flows used in operating activities | (1447) | (46935) | (15005) | (86013) |
| Capital expenditures | (3748) | (14226) | (10699) | (20420) |
| **Free Cash Flow** | **(5195)** | **(61161)** | **(25704)** | **(106433)** |

---

Free cash flow was an outflow of $25.7 million for the six months ended June 30, 2025 compared to an outflow of $106.4 million during the prior year period. The improvement in free cash flow was driven by decreased net cash flows used in operating activities and lower capital expenditures.

------

##  ***Segment Information*** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Revenue, Adjusted EBITDA and EBITDA** |  |  |  |  |  |  |
| **Three months ended June 30, 2025<br>(Unaudited)<br>(in thousands of U.S. dollars)** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 118193 | 63185 | 26976 |  |  | 208354 |
| Intersegment revenue | 455 |  |  |  | (455) |  |
| **Total segment revenue** | **118648** | **63185** | **26976** | **—** | **(455)** | **208354** |
| **Adjusted EBITDA** | **24261** | **(2369)** | **(636)** | **(24819)** | **—** | **(3563)** |
| Share-based compensation expense | (515) | (328) | (334) | (2276) |  | (3453) |
| Restructuring costs<sup>(1)</sup> | (471) | (585) | (42) | (295) |  | (1393) |
| Strategic review of Greater China business<sup>(2)</sup> |  |  | (1378) |  |  | (1378) |
| Non-controlling interests |  |  | (35) |  |  | (35) |
| **EBITDA** | **23275** | **(3282)** | **(2425)** | **(27390)** | **—** | **(9822)** |
| Finance income and (expenses), net |  |  |  |  |  | (31916) |
| Depreciation and amortization |  |  |  |  |  | (12294) |
| **Loss before tax** | **—** | **—** | **—** | **—** | **—** | **(54032)** |
| **Three months ended June 30, 2024<br>(Unaudited)<br>(in thousands of U.S. dollars)** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 105541 | 67819 | 28835 |  |  | 202195 |
| Intersegment revenue | 1814 |  |  |  | (1814) |  |
| **Total segment revenue** | **107355** | **67819** | **28835** | **—** | **(1814)** | **202195** |
| **Adjusted EBITDA** | **12638** | **1166** | **(428)** | **(24373)** | **—** | **(10997)** |
| Share-based compensation expense | (501) | (232) | (479) | (2967) |  | (4179) |
| Restructuring costs<sup>(1)</sup> | (855) | (769) | (1470) | (120) |  | (3214) |
| Discontinued construction of production facilities<sup>(4)</sup> | (2923) | 277 |  |  |  | (2646) |
| New product launch issue<sup>(5)</sup> |  | (5677) |  |  |  | (5677) |
| Non-controlling interests |  |  | (58) |  |  | (58) |
| **EBITDA** | **8359** | **(5235)** | **(2435)** | **(27460)** | **—** | **(26771)** |
| Finance income and (expenses), net |  |  |  |  |  | 10389 |
| Depreciation and amortization |  |  |  |  |  | (12308) |
| **Loss before tax** |  |  |  |  |  | **(28690)** |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Six months ended June 30, 2025 <br>(in thousands of U.S. dollars)** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 225858 | 123071 | 56955 |  |  | 405884 |
| Intersegment revenue | 1144 |  |  |  | (1144) |  |
| **Total segment revenue** | **227002** | **123071** | **56955** | **—** | **(1144)** | **405884** |
| **Adjusted EBITDA** | **39797** | **(1240)** | **982** | **(46833)** | **—** | **(7294)** |
| Share-based compensation expense | (983) | (686) | (723) | (4653) |  | (7045) |
| Restructuring costs<sup>(1)</sup> | (471) | (1253) | (42) | (459) |  | (2225) |
| Strategic review of Greater China business<sup>(2)</sup> |  |  | (1378) |  |  | (1378) |
| Closure of production facility<sup>(3)</sup> | 846 |  |  |  |  | 846 |
| Non-controlling interests |  |  | (136) |  |  | (136) |
| **EBITDA** | **39189** | **(3179)** | **(1297)** | **(51945)** | **—** | **(17232)** |
| Finance income and (expenses), net |  |  |  |  |  | (22505) |
| Depreciation and amortization |  |  |  |  |  | (23475) |
| **Loss before tax** | **—** | **—** | **—** | **—** | **—** | **(63212)** |
| **Six months ended June 30, 2024 <br>(in thousands of U.S. dollars)** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 215948 | 134786 | 50616 |  |  | 401350 |
| Intersegment revenue | 3778 |  |  |  | (3778) |  |
| **Total segment revenue** | **219726** | **134786** | **50616** | **—** | **(3778)** | **401350** |
| **Adjusted EBITDA** | **27134** | **778** | **(3856)** | **(48257)** | **—** | **(24201)** |
| Share-based compensation expense | (879) | 1027 | (1179) | (5763) |  | (6794) |
| Restructuring costs<sup>(1)</sup> | (855) | (769) | (1940) | (71) |  | (3635) |
| Discontinued construction of production facilities<sup>(4)</sup> | (2923) | 1161 |  |  |  | (1762) |
| New product launch issue<sup>(5)</sup> |  | (5677) |  |  |  | (5677) |
| Non-controlling interests |  |  | (102) |  |  | (102) |
| **EBITDA** | **22477** | **(3480)** | **(7077)** | **(54091)** | **—** | **(42171)** |
| Finance income and (expenses), net |  |  |  |  |  | (6988) |
| Depreciation and amortization |  |  |  |  |  | (25321) |
| **Loss before tax** | **—** | **—** | **—** | **—** | **—** | **(74480)** |

---

\* Corporate consists of general costs not allocated to the segments.

\*\* Eliminations in 2025 and 2024 refer to intersegment revenue for sales of products from Europe & International to Greater China.

(1) Relates primarily to severance costs as the Group adjusts its organizational structure.

(2) Relates to costs for the strategic review of the Greater China segment.

(3) Relates to reversal of previously recognized exit costs related to closure of the Group's production facility in Singapore.

(4) Relates primarily to non-cash impairments related to discontinued construction of the Group's production facility in Peterborough, UK, and reversal of previously recognized non-cash impairments related to discontinued construction of the Group's production facility in Dallas-Fort Worth, Texas.

(5) Expenses related to a new product launch issue.

##  ***Off-Balance Sheet Arrangements*** 
We did not have during the period presented, and we do not currently have, any off-balance sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

##  ***Critical Accounting Policies and Significant Judgments and Estimates*** 
We prepare our interim condensed consolidated financial statements in accordance with IAS 34 *Interim Financial Reporting*. Preparing these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenue, expenses, and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results may differ from these estimates. Other companies in similar businesses may use different estimation policies and methodologies, which may impact the comparability of our financial condition, results of operations and cash flows to those of other companies.

------

Our critical accounting policies are described under the heading "Critical Accounting Estimates" in our 2024 Annual Report and the notes to the audited financial statements in our 2024 Annual Report. Our critical accounting policies and estimates are the same as those discussed in our 2024 Annual Report.

***Recent Accounting Pronouncements***

Refer to Note 2 *Summary of accounting policies* to our interim condensed consolidated financial statements appearing elsewhere in this Report.

##  ***Item 3. Qualitative and Quantitat ive Disclosures about Market Risk*** 
We are exposed to certain market risks in the ordinary course of our business. These risks primarily consist of foreign exchange risk, interest rate risk, credit risk, liquidity risk and commodity price risk. For further discussion and sensitivity analysis of these risks, see Note 3 *Financial risk management* to our audited consolidated financial statements for the year ended December 31, 2024 included in our 2024 Annual Report.

# **Part II – OTHER INFORMATION** 

##  ***Item 1. Legal Proceedings*** 
From time to time, we may be involved in various claims and legal proceedings related to claims arising out of our operations. We are not currently a party to any material legal proceedings, including any such proceedings that are pending or threatened, of which we are aware.

##  ***Item 1A. R isk Factors*** 
There have been no material changes to our risk factors since those reported in Part I, Item 3.D. *"Risk Factors"* of our 2024 Annual Report other than as noted below:

***The Strategic Review of our China Business may not be successful***

We have initiated a strategic review of our Greater China business. The review will consider a broad range of strategic options to enhance shareholder value, including a potential carve-out of the Greater China segment. There is no guarantee that this strategic review will be successful or will yield results that enhance shareholder value. The strategic review will also take time and the attention of management. The strategic review may also take longer than expected. There are no assurances that the process will result in any transaction or strategic change. If the strategic review is not successful, this will likely have a negative result on our business, results of operations and financial condition.

##  ***Item 2. Unregistered Sales of Equ ity Securities and Use of Proceeds*** 

##  ***Use of Proceeds*** 
The information contained in Item 2 in Part II of the Company's Report on Form 6-K filed on November 15, 2021 is incorporated by reference herein.

##  ***Item 3. Defaults Upo n Senior Securities*** 
None.

------

**Signatures**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Oatly Group AB** | **Oatly Group AB** |
| Date: July 23, 2025 | By: | /s/ Marie-José David |
|  | Name: | Marie-José David |
|  | Title: | Chief Financial Officer |

---

------